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1. INTRODUCTION  
Nature is the abundant source of medicinal plants. The use of medicinal plants is from 
ancient times onward. Till today majority of people rely on such traditional remedies. Many 
of compounds used for the production of modern medicines were also derived from the herbs 
in the surroundings. 
Because of their ability to synthesize a wide variety of chemical compounds that can 
be used to perform important biological functions, their phytochemicals have been processed 
for beneficial effects on long-term health when consumed by humans, and can be used to 
effectively treat human diseases. At least 12,000 such compounds have been isolated so far, a 
number estimated to be less than 10% of the total.1 
The term "herbs" refers to plants or parts of them, including grasses, flowers, berries, 
seeds, leaves, nuts, stems, stalks and roots, which are used for their therapeutic and health- 
enhancing properties. Generations of skilled herbal practitioners, researchers and scholars 
have refined and tested the vast science of herbology, producing thousands of plant-based 
remedies that are safe and effective. 
An estimated eighty percent (80%) of the world's population employs herbs as 
primary medicines 
Ayurveda, Siddha and Unani systems of medicine provide good base for scientific 
exploration of medicinally important molecules from nature. 
 
    India is rightly called the botanical garden of the world and perhaps the largest 
producer of medicinal herbs. India recognizes over 3000 plants for their medicinal value. It is 
estimated that over 6000 plants in India are in use in traditional, folk and herbal medicine i.e. 
75% of the medicinal needs of the world countries. Medicinal herbs are used in one form or 
another, under indigenous systems of medicine like Ayurveda, Siddha & Unani.  
India holds its history in herbal remedy and found to be so popular that the government 
of India has created a separate department ‘AYUSH’ under the Ministry of Health & Family 
Welfare. In 2000, the National Medicinal plants Board was established by Indian government 
in order to deal with the herbal medicinal system. 
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Traditional therapy is supported by evidence on safety and effectiveness. Usually, these 
evidences were found on sources such as pharmacopoeias, traditional scriptures, and/ or 
clinical experience registered over hundreds of years. At present, an increasing number of 
scientific studies support the use of herbal therapy. The advantages of traditional medicine 
include its diversity and flexibility, availability and affordability. It is of comparatively low 
cost and merely requires relatively low level of technological input. However, there is a need 
for an increase in research to improve the evidence base as regards to efficacy.2 
PLANT MEDICINES, SAFER AND TIME-TESTED  
Plant medicines are far and away safer, gentler and better for human health than synthetic 
drugs. This is so because human beings have co-evolved with plants over the past few million 
years.3 
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2. LITERATURE REVIEW 
2.1 MEMORY 4,5 
 Memory is the processes by which information is encoded, stored, and retrieved.  
 There are three main stages in the formation and retrieval of memory: 
Encoding or registration (receiving, processing and combining of received information) 
 Storage  (creation of a permanent record of the encoded information) 
 Retrieval, recall or recollection (calling back the stored information in response to 
some clue for use in a process or activity) 
 Encoding allows information that is from the outside world to reach our senses in the 
forms of chemical and physical stimuli. In this first stage we must change the 
information so that we may put the memory into the encoding process. Storage is the 
second memory stage or process. This entails that we maintain information over 
periods of time. Finally the third process is retrieval. This is the retrieval of 
information that we have stored. We must locate it and return it to our consciousness. 
Some retrieval attempts may be effortless due to the type of information. 
SENSORY MEMORY 
Sensory memory corresponds approximately to the initial 200–
500 milliseconds after an item is perceived. The ability to look at an item, and 
remember what it looked like with just a second of observation, or memorisation, is 
an example of sensory memory. 
Short term memory 
Short-term memory allows recall for a period of several seconds to a minute 
without rehearsal. Its capacity is also very limited. However, memory capacity can be 
increased through a process called chunking 
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Long-term memory 
     Long-term memory can store much larger quantities of information for potentially 
unlimited duration (sometimes a whole life span). Its capacity is immeasurably large. Long-
term memories, on the other hand, are maintained by more stable and permanent changes in 
neural connections widely spread throughout the brain. The hippocampus is essential (for 
learning new information) to the consolidation of information from short-term to long-term 
memory, although it does not seem to store information itself. Without the hippocampus, new 
memories are unable to be stored into long-term memory, as learned from HM after removal 
of his hippocampus, and there will be a very short attention span. Furthermore, it may be 
involved in changing neural connections for a period of three months or more after the initial 
learning. Several studies have demonstrated that memory depends on getting sufficient sleep 
between training and test. Additionally, data obtained from neuroimaging studies have shown 
activation patterns in the sleeping brain which mirror those recorded during the learning of 
tasks from the previous day, suggesting that new memories may be solidified through such 
rehearsal 
Ameriolative Effect Of Hydro Alcoholic Extract Of Caryota urens STZ Induced Alzheimer’s  
 
Department of Pharmacology Page 5 
 
2.2 AMNESIA6
 
 Amnesia is a condition in which one's memory is lost. The causes of amnesia have 
traditionally been divided into certain categories. Memory appears to be stored in several 
parts of the limbic system of the brain, and any condition that interferes with the function of 
this system can cause amnesia. Functional causes are psychological factors, such as post-
traumatic stress or, in psycho analytic terms, defense mechanism.  
 Anterograde amnesia is the loss of long-term memory, the loss or impairment of the 
ability to form new memories through memorization. People may find themselves constantly 
forgetting a piece of information, people or events after a few seconds or minutes, because 
the data does not transfer successfully from their conscious short-term memory into 
permanent long-term memory. Primarily in older men, transient global amnesia causes severe 
loss of memory for minutes or hours. 
 Retrograde amnesia, the loss of pre-existing memories to conscious recollection, 
beyond an ordinary degree of forgetfulness. This type of amnesia first targets the patient's 
most recent memories. The amount of memories lost depends on the severity of the case. The 
person may be able to memorize new things that occur after the onset of amnesia (unlike in 
antero grade amnesia), but is unable to recall some or all of their life or identity prior to the 
onset. The effect of retrograde amnesia (RA) occurs on fact memory to a lower degree than it 
occurs on autobiographical memory, which can be affected over the whole lifespan of the 
patient by RA. There have also been some cases where retrograde amnesia is a result of 
hypoglycemia in insulin-dependent diabetic patients.  
However, there are different types of memory, for example procedural memory (i.e. 
automated skills) and declarative memory (personal episodes or abstract facts), and often 
only one type is impaired. For example, a person may forget the details of personal identity, 
but still retain a learned skill such as the ability to play the piano. 
In addition, the terms are used to categorize patterns of symptoms rather than to 
indicate a particular cause (etiology). Both categories of amnesia can occur together in the 
same patient, and commonly result from drug effects or damage to the brain regions most 
closely associated with episodic memory: the medial temporal lobes and especially 
the hippocampus. 
An example of mixed retrograde and antero grade amnesia, may be a motorcyclist 
unable to recall driving his motorbike prior to his head injury (retrograde amnesia), nor can 
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he recall the hospital ward where he is told he had conversations with family over the next 
two days (antero grade amnesia). 
The most influential case on anter ograde amnesia was H.M. This patient had to 
undergo bi-lateral removal of the hippocampus and amygdala in order to treat his severe 
epilepsy. In fact, H.M. was reported having up to 10 seizures per day. Although the epilepsy 
was fixed through surgery H.M. ended up with antero grade amnesia.   
The effects of amnesia can last a long time even after the condition has passed. Some 
sufferers claim that their amnesia changes from a neurological condition to also being a 
psychological condition, whereby they lose confidence and faith in their own memory and 
accounts of past events. 
Another effect of some forms of amnesia may be impaired ability to imagine future 
events. A 2006 study showed that future experiences imagined by amnesics with bilaterally 
damaged hippocampus lacked spatial coherence, and the authors speculated that the 
hippocampus may bind different elements of experience together in the process of re-
experiencing the past or imagining the future. 
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2.3 NEURODEGENERATION  
Neurodegeneration is the umbrella term for the progressive loss of structure or 
function of neurons, including death of neurons. Many neurodegenerative diseases including 
ALS, Parkinson’s, Alzheimer’s, and Huntington’s occur as result of neurodegenerative 
processes. As research progresses, many similarities appear that relate these diseases to one 
another on a sub-cellular level. Discovering these similarities offers hope for therapeutic 
advances that could ameliorate many diseases simultaneously. There are many parallels 
between different neurodegenerative disorders including atypical protein assemblies as well 
as induced cell death. Neurodegeneration can be found in many different levels of neuronal 
ranging from molecular to systemic.7 
The term neurodegeneration is a combination of two words - "neuro," referring to 
nerve cells and "degeneration," referring to progressive damage. The term 
"neurodegeneration" can be applied to several conditions that result in the loss of nerve 
structure and function.  
This deterioration gradually causes a loss of cognitive abilities such as memory and 
decision making. Neurodegeneration is a key aspect of a large number of diseases that come 
under the umbrella of neurodegenerative diseases. Of these hundreds of different disorders, 
so far attention has been mainly focused on only a handful, with the most notable being 
Parkinson’s disease, Huntington disease and Alzheimer’s disease. A large proportion of the 
less publicized diseases have essentially been ignored.  
All of these conditions lead to progressive brain damage and neurodegeneration. 
Although all three of the diseases manifest with different clinical features, the disease 
processes at the cellular level appear to be similar. For example, Parkinson's disease affects 
the basal ganglia of the brain, depleting it of dopamine. This leads to stiffness, rigidity and 
tremors in the major muscles of the body, typical features of the disease. In Alzheimer's 
disease, there are deposits of tiny protein plaques that damage different parts of the brain and 
lead to progressive loss of memory. Huntington's disease is a progressive genetic disorder 
that affects major muscles of the body leading to severe motor restriction and eventually 
death.8  
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2.4 NEURODEGENERATIVE DISEASES 
ALZHEIMER'S DISEASE  
Alzheimer's disease is characterized by loss of neurons and synapses in the cerebral 
cortex and certain subcortical regions. This loss results in gross atrophy of the affected 
regions, including degeneration in the temporal lobe and parietal lobe, and parts of the frontal 
cortex and cingulate gyrus.   
Alzheimer's disease has been hypothesized to be a protein misfolding disease 
(proteopathy), caused by accumulation of abnormally folded beta amyloid and tau proteins in 
the brain. Plaques are made up of small peptides, 39–43 amino acids in length, called beta-
amyloid Beta-amyloid is a fragment from a larger protein called amyloid precursor protein 
(APP), a transmembrane protein that penetrates through the neuron's membrane. APP is 
critical to neuron growth, survival and post-injury repair. In Alzheimer's disease, an unknown 
process causes APP to be divided into smaller fragments by enzymes through proteolysis. 
One of these fragments gives rise to fibrils of beta-amyloid, which form clumps that deposit 
outside neurons in dense formations known as senile plaques.9  
Parkinson’s disease  
Parkinson's disease is the second most common neurodegenerative disorder and 
manifests as bradykinesia, rigidity, resting tremor and posture instability. Parkinson's disease 
is a degenerative disorder of the central nervous system. It results from the death of 
dopamine- generating cells in the substantia nigra, a region of the midbrain; the cause of cell-
death is unknown.  
The mechanism by which the brain cells in Parkinson's are lost may consist of an 
abnormal accumulation of the protein alpha-synuclein bound to ubiquitin in the damaged 
cells. The alpha- synuclein-ubiquitin complex cannot be directed to the proteosome. This 
protein accumulation forms proteinaceous cytoplasmic inclusions called Lewy bodies.10  
Huntington’s disease  
Huntington’s disease causes astrogliosis and loss of medium spiny neurons. Areas of 
the brain are affected according to their structure and the types of neurons they contain, 
reducing in size as they cumulatively lose  cells. The areas affected are mainly in the 
striatum, but also the frontal and temporal cortices. The striatum's subthalamic nuclei send 
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control signals to the globus pallidus, which initiates and modulates motion. The weaker 
signals from subthalamic nuclei thus cause reduced initiation and modulation of movement, 
resulting in the characteristic movements of the disorder.  
Mutant Huntington is an aggregate-prone protein. During the cells' natural clearance 
process, these proteins are retro grade transported to the cell body for destruction by 
lysosomes. It is a possibility that these mutant protein aggregates damage the retrograde 
transport of important cargoes such as BDNF by damaging molecular motors as well as 
microtubules.11   
Amyotrophic lateral sclerosis (ALS)  
Amyotrophic lateral sclerosis (ALS/Lou Gehrig’s Disease) is a disease in which 
motor neurons are selectively targeted for degeneration. In 1993, missense mutations in the 
gene encoding the antioxidant enzyme Cu/Zn superoxide dismutase 1 (SOD1) were 
discovered in subsets of patients with familial ALS. This discovery led researchers to focus 
on unlocking the mechanisms for SOD1-mediated diseases. However, the pathogenic 
mechanism underlying SOD1 mutant toxicity has yet to be resolved. More recently, TDP-43 
and FUS protein aggregates have been implicated in some cases of the disease, and a 
mutation in chromosome 9 (C9orf72) is thought to be the most common known cause of 
sporadic ALS.12   
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2.5 ALZHEIMER'S DISEASE  
 
Alzheimer's disease (AD) is a progressive brain disorder that gradually impairs 
memory and ability to learn, reasoning, judgment, communication and daily activities. AD is 
characterized clinically by cognitive impairment and pathologically by the deposition of β 
amyloid plaques and neurofibrillary tangles, and the degeneration of the cholinergic basal 
forebrain13. In the advance stage, motor weakness increases that leads to muscular 
contractures which produces immobility such as pneumonia, pulmonary embolism and death. 
At present no direct ante mortem confirmatory test exists14. Although the risk of developing 
Alzheimer’s disease increases with age in most people, symptoms first appear after age 6015. 
According to World Health Organization projections, about three-quarters of the estimated 
1.2 billion elders will be living in low- and middle-income countries by the year 2025.  
Epidemiological studies conducted in India between 1996 indicated that dementia affects 
2.7% of the population, AD being the most common cause (1.3%).16 
 
HISTORY  
Auguste D. was first alzheimer patient who admitted to Frankfurt’s Hospital for the 
Mentally Ill and Epileptics in 1901. Dr. Alois Alzheimer, had been a doctor at the hospital for 
some 13 years but was still baffled by her case and so took an unusual interest in it. Even 
after a career move to the Royalc Psychiatric Clinic in Munich in 1903, Alzheimer continued 
to follow the progression of Auguste D.’s illness from a distance. As a consequence, when 
she died in April 1906, the director of the Frankfurt hospital sent her brain to Alzheimer, who 
used it to produce the recently rediscovered 250 sample slides. Hence the disease was named 
after him.17 
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2.6. CAUSES 18 
Increased risk 
Although it's still unknown what triggers Alzheimer's disease, several factors are 
known to increase your risk of developing the condition. 
Age 
Age is the single most significant factor in the development of Alzheimer's disease. 
The likelihood of developing the condition doubles every five years after you reach 65 years 
of age. However, it's not just older people who are at risk of developing Alzheimer's disease. 
Around 1 in 20 people with the condition are under 65. This is called early onset Alzheimer's 
disease and it can affect people from around the age of 40. 
Family history 
The genes you inherit from your parents can contribute to your risk of developing 
Alzheimer's disease, although the actual increase in risk is small if you have a close family 
member with the condition. However, in a few families, Alzheimer's disease is caused by the 
inheritance of a single gene, and the risks of the condition being passed on are much higher. 
If several of your family members have developed dementia over the generations, it may be 
appropriate to seek genetic counselling for information and advice about your chances of 
developing Alzheimer's disease when you are older. 
Down's syndrome 
People with Down's syndrome are at a higher risk of developing Alzheimer's disease. 
This is because the genetic fault that causes Down's syndrome can also cause amyloid 
plaques to build up in the brain over time, which can lead to Alzheimer's disease in some 
people. 
Head injuries 
People who have had a severe head injury have been found to be at higher risk of 
developing Alzheimer's disease. 
Cardiovascular disease 
Research shows that several lifestyle factors and conditions associated 
with cardiovascular disease can increase the risk of Alzheimer's disease. these include 
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 smoking 
 obesity 
 diabetes 
 high blood pressure 
 high cholesterol 
 
2.7 THEORIES OF ALZHEIMER'S DISEASE 19 
 Five theories are warrant to determine the actual cause of this disease: 
 1. Chemical Theory: Biochemical Deficiencies: Brain cells communicate with each other 
through biochemical substances called as neurotransmitters. Studies of Alzheimer's disease 
brains have uncovered diminished levels of various neurotransmitters that are thought to 
influence intellectual functioning and behavior. Toxic Chemical Excesses: Increased deposits 
of metal ions such as aluminum, Lead, etc have been found in Alzheimer's disease brains. 
 2. Genetic Theory: This theory explains the inheritance of a gene which directs the 
production of apolipoprotein (ApoE). In early-onset Alzheimer's, mutation on chromosome 
14 which accounts for 10% of Alzheimer's cases. Additionally, a mutation was also found out 
on chromosomes 1 and 21. In 1997, another mutation on chromosome 12 effectively linked to 
late onset Alzheimer's. 
 3. Autoimmune Theory: The body's immune system, which protects against potentially 
harmful invaders, may erroneously begin to attack its own tissues, producing antibodies to its 
own essential cells.  
4. Slow Virus Theory: A slow-acting virus has been identified as a causative agent for 
Alzheimer's disease.  
5. Blood Vessel Theory: Defects in blood vessels supplying blood to the brain are being 
studied as a possible cause of Alzheimer's.   
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2.8 ALZHEIMER STATISTICS 
 Worldwide, at least 47.5 million people are living with dementia, making the disease a global 
health crisis that must be addressed. Alzheimer's disease is the most common cause of 
dementia and may contribute to 60–70% of cases.  
 The global number will increase to an estimated 75.6 million in 2030, and will 
almost triple by 2050 to 135.5 million.20 
 Total health-care costs for people with dementia amount to more than 1 per cent of the global 
gross domestic product (GDP), or US$604 billion in 2010.21 
 The number of Americans living with Alzheimer's disease is growing fast. An estimated 5.4 
million Americans of all ages have Alzheimer's disease in 2016.Of the 5.4 million Americans 
with Alzheimer's, an estimated 5.2 million people are age 65 and older, and approximately 
200,000 individuals are under age 65.These numbers will escalate rapidly in coming years. 
By 2050, the number of people age 65 and older with Alzheimer's disease may nearly triple, 
from 5.2 million to a projected 13.8 million.22  
 An estimated 564,000 Canadians are living with dementia  
 In china about 9.2 million people suffering from dementia (2010)  
2.9 ALZHEIMERS IN INDIA  
 In India, more than 4 million people have some form of dementia.  
 being second largest country in world, India has less number of alzheimers patient.  
 curcumin, commonly known as  haldi  in India, helps reduce the risk of Alzheimer's disease, a 
brain disorder that results in memory loss, personality changes and a decline in the thinking 
ability. These adverse impacts, scientists believe, are related to the death of brain cells and a 
breakdown of connections. 23 
 As per a study conducted by scientists from the US -based University of California, curcumin 
inhibits the accumulation of destructive beta amyloids  inert substances responsible for 
Alzheimer's  in the brain. The study, involving genetically altered mice, suggests curcumin is far 
more effective in inhibiting formation of the amyloids than drugs currently being tested to treat 
the disease  
 They assert the extensive use of curcumin is possibly why India has the lowest rate of the disease 
in the world  about 4.4 times less among adults aged 70-79 than the rate in the us.24 
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2.10 STAGES FOR ALZHEIMER 25 
Evaluating Prescription Drugs Used to Treat: Alzheimer’s Disease • Consumer Reports Best 
Buy Drugs
 
Not Alzheimer’s  
 Forgetting things occasionally. 
 Misplacing items, like keys, eye glasses, bills, paper work. 
 Forgetting the names or titles of some things, like movies, books, people’s names. 
 Some reduction in ability to recall words when speaking. 
 Being “absent-minded” or sometimes hazy on details. 
 ”Spacing out on things,” such as appointments. 
 
Early stage 
 Short-term memory loss, usually minor. 
 Being unaware of the memory lapses. 
 Some loss, usually minor, in ability to retain recently learned information . 
 Forgetting things and unable to dredge them up, such as the name of a good friend or, 
even, family member. 
 Function at home normally with minimal mental confusion, but may have problems at 
work or in social situations. 
 Symptoms may not be noticeable to all but spouse or close relatives/friends. 
 
Middle-stage  
 Short-term memory loss deepens, may begin to forget conversations completely, or 
names of loved ones 
 Mental confusion deepens, trouble thinking logically 
 Some loss of self-awareness  
 Friends and family notice memory lapses 
 May become disoriented, not know where you are  
 Impaired ability to perform even simple arithmetic 
 May become more aggressive or passive  
 Difficulty sleeping  
Ameriolative Effect Of Hydro Alcoholic Extract Of Caryota urens STZ Induced Alzheimer’s  
 
Department of Pharmacology Page 15 
 
Late-stage 
 Severe cognitive impairment and short-term memory loss  
 Speech impairment 
 May repeat conversations over and over  
 May not know names of spouse, children, or care givers, or what day or month it is 
 Very poor reasoning ability and judgment  
 Neglect of personal hygiene 
 Personality changes; may become abusive, highly anxious, agitated, delusional, or 
even paranoid  
 Needs extensive assistance with activities of daily living 
 
 
FIG 1: Stages of Alzheimer’s disease 
As Alzheimer’s disease progresses, neuro fibrillary tangles spread throughout the brain 
shown in blue 
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2.11 SIGNS 26 
Memory loss that affects day-to-day abilities  
It’s normal to occasionally forget appointments, colleagues’ names or a friend’s 
phone number and remember them later. A person with Alzheimer’s disease may forget 
things more often or have difficulty recalling information that has recently been learned.  
Difficulty performing familiar tasks  
Busy people can be so distracted from time to time that they may forget to serve part 
of a meal and only remember later. A person with Alzheimer’s disease may have trouble 
completing tasks that have been familiar to them all their lives, such as preparing a meal or 
playing a game.  
Problems with language  
Everyone has trouble finding the right word sometimes, but a person with 
Alzheimer’s disease may forget simple words or substitute words, making sentences difficult 
to understand.  
Disorientation in time and space  
It’s normal to forget the day of the week or your destination - for a moment. But 
people with Alzheimer’s disease can become lost on their own street, not knowing how they 
got there or how to get home.  
Impaired judgment 
From time to time, people can make questionable decisions such as putting off seeing 
a doctor when they have an infection. A person with Alzheimer’s disease may experience 
changes in judgment or decision-making, for example not recognizing a medical problem that 
needs attention or wearing heavy clothing on a hot day.  
Problems with abstract thinking  
From time to time, people may have difficulty with tasks that require abstract 
thinking, such as balancing a cheque book. Someone with Alzheimer’s disease may have 
significant difficulties with such tasks, for example not understanding what numbers are and 
how they are used.  
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Misplacing things  
Anyone can temporarily misplace a wallet or keys. A person with Alzheimer’s disease 
may put things in inappropriate places: an iron in the freezer or a wristwatch in the sugar 
bowl. 
Changes in mood and behaviour 
Everyone becomes sad or moody from time to time. Someone with Alzheimer’s 
disease can exhibit varied mood swings - from calm to tears to anger - for no apparent reason. 
Alzheimer Society of Canada 
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2.12 DIAGNOSIS 27 
 
Diagnostic Criteria 
 
The only method of definitively diagnosing AD is a brain autopsy. However, mental 
and behavioral tests and physical examinations allow physicians to make an accurate 
diagnosis of AD in 90 percent of cases. 
The first step in finding a diagnosis is obtaining the patient history. During this time, 
the physician will determine what symptoms are present, when they began, and how they 
have progressed over time. The family history of illness is also pertinent. The physician will 
perform a physical examination, including blood tests and urinalysis. This is done to rule out 
other potential causes of dementia, such as hormone imbalance, vitamin deficiency, and 
urinary tract infections. Brain scans may also be performed to exclude tumors, cerebro 
vascular accidents, traumatic brain injury, and infections. These scans are also helpful in 
identifying the characteristic tangles and plaques seen in AD. Structural imaging scans, 
including magnetic resonance imaging (MRI) and computed tomography (CT), provide 
information about the shape and volume of the brain. Functional imaging allows the 
physician to determine how effectively the brain cells are working. A functional MRI or 
positron emission tomography (PET) scan can be used 
 
2.13 DETECTION TECHNIQUES 27 
 
CT SCAN 
CT scans can be accurate in diagnosing AD and ruling out other possible causes of the 
symptoms. However, this type of scan is more effective during the later stages of the disease. 
This technique is most often used to identify the neuro fibrillary tangles and beta-amyloid 
plaques seen during advanced stages of AD. In early diagnosis, research has shown that both 
the MRI and PET scans are more effective. 
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MRI  
Magnetic resonance imaging (MRI) techniques, first , create two or three-dimensional 
images of the body that can be used to diagnose injury and illness. The MRI was used to 
detect the hippocampal volume and determine its significance as an indicator of AD 
neuropathology 
PET 
 Positron emission tomography (PET) uses radiation signals to create a three 
dimensional color image of the human body. A PET scan has the capacity to detect changes 
in metabolism, blood flow, and cellular communication processes in the brain 
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2.14 PATHOLOGY 
 
PLAQUES AND TANGLES 
 
There is two abnormal structures in their Alzheimer brains, both amyloid plaques and 
neuro fibrillary tangles. These are particularly common in regions of the brain that are very 
important in the creation of memory. Plaques consist mainly of dense, insoluble deposits of 
protein and cellular material that build up around and outside neurons. Tangles are twisted, 
insoluble fibres that develop inside nerve cells. While such structures can be found in limited 
numbers in the brains of many healthy elderly people, they are present to a much greater 
degree in those who have shown the symptoms of Alzheimer’s disease. 28 
 
 
 
 
                         Healthy Brain               Severe Alzheimer’s 
 
Fig 2: Cross sections of the brain show atrophy, or shrinking, of brain tissue caused by 
Alzheimer’s disease. 
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Beta amyloid 
In the normal brain, a larger protein the amyloid precursor protein is broken down 
into three smaller protein fragments known as alpha-amyloid, beta-amyloid, and gamma-
amyloid. In those individuals with Alzheimer’s disease, when amyloid precursor protein 
breaks down it creates a disproportionate amount of beta-amyloid but less alpha-amyloid and 
gamma-amyloid protein than usual. This excess of beta-amyloid protein overwhelms the 
brain’s capacity to remove it and so it accumulates as insoluble gum like plaques, which may 
also contain other molecules, neurons, and non-nerve cells. 
Such plaques “gum up the works” by damaging the connection points that is the 
synapses, between neurons and, as a consequence, interfere with such cells’ ability to 
communicate. In Alzheimer’s disease, early plaques develop in the hippocampus, a brain 
structure involved in encoding memories, and also in other parts of the cerebral cortex that 
are necessary for thought and decision making. As the disease progresses, additional plaques 
form in the frontal lobes of the brain. The more severe the symptoms of Alzheimer’s disease, 
the more plaques will typically be found in the patient’s brain during autopsy. Such beta-
amyloid plaques also trigger an inflammatory response. Part of this process involves the 
creation of oxygen free radicals highly reactive molecules which can damage or kill other 
cells by creating holes in their membranes or binding to their DNA and interfering with 
survival. This plaque-related inflammatory process appears to destroy large numbers of brain 
cells in Alzheimer’s patients and its effects are obvious in stained brain sections. This could 
be why taking anti-inflammatory drugs, for other health problems, may accidentally reduce 
the probability of developing Alzheimer’s disease. 29 
 
 
Fig 3 : Formation Of Amyliod Plaques 
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Tangles 
 Tau is important protein,that normally binds with tubulin, which is used to form 
structures known as microtubules. These microtubules are of great biological significance 
because they act like the pillars and girders of a building, giving shape and structure to cells. 
In patients with Alzheimer’s disease, tau becomes chemically abnormal and begins to pair 
with other threads of tau and become tangled. As this happens, neuron microtubules 
disintegrate. These “tangles” prevent the movement of nutrients and other molecules to the 
nerve endings of the neurons, and as a result, communication malfunctions can occur, often 
followed by cell death. Tangles initially interfere with the functions of the brain’s temporal 
lobe, causing memory loss and difficulties in reading and writing. As plaques and tangles 
begin to appear in the frontal lobes, personality disorders and other symptoms appear. While 
tangles can be seen also in the brains of healthy older people, they are relatively rare. In 
Alzheimer’s patients, the worse the symptoms, the more common tangles are usually found to 
be on brain autopsy. 
Normally tau protein undergoes phosphorylation, the addition of a phosphate (PO4) 
group to a protein or to a small molecule. Phosphorylation provides a very fast way of 
regulating proteins. If a protein, is regulated by phosphorylation it is always present in 
“standby” mode. When an activating signal arrives, the protein is phosphorylated and then 
performs in the way intended .the tau in the brains of Alzheimer’s patients is abnormal in that 
it is hyperphosphorlylated, that is phosphorlylated to excess. It has been corrupted by several 
extra molecules of phosphorus. As a result, the tau malfunctions and becomes unable to 
support tubulin’s role in the production of microtubules, which, therefore, lack integrity and 
begin to twist. Communication and cell nourishment is compromised and eventually declines 
to zero. The neuron cannot be sustained and begins to wither. The cell membranes collapse 
and every part of the neuron disintegrates and with it synapses, each representing a memory 
fragment. 30 
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Fig 4 : Formation Of TAU tangles 
 
 
Nucleus Basalis Of Meynert   
 
Plaques and tangles do not seem to be the only cause of Alzheimer’s related neuron 
death. Certain neurons found at the base of the brain known as the Nucleus Basalis of 
Meynert, appear to die in Alzheimer’s disease without any evidence of the interference of 
plaques or tangles. Such neurons produce acetylcholine, a chemical messenger used in 
communication between neurons. Normally acetylcholine-manufacturing neurons have long 
branches that reach into the hippocampus and cortex and are thought to play an important 
role in learning and memory. Their death in Alzheimer’s disease means that less 
acetylcholine is available to the brain, probably interfering with both its memory and learning 
capacity. 31 
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Genetics 
 
Alzheimer’s disease seems linked, to some degree, to a gene in chromosome  called 
the APO E gene, which codes for apolipoprotein E. This protein is involved in the cellular 
movement of cholesterol throughout the body. There are three slightly different types (known 
as alleles) of the APO E gene, namely APO E2, APO E3, and APO E4. Everybody has 
inherited two copies of this gene, one from each parent. The E3 variant is the most common 
and occurs in between 40 and 90 percent of the populations of particular regions; E2 and E4 
are less common, being present in 2 percent and 6 to 37 percent of people respectively.It has 
been demonstrated that the probability of developing sporadic late-onset Alzheimer’s disease 
is much higher in those possessing the EPO E4 allele. Indeed, anyone who has inherited 
copies of the APO E4 alelle from both parents has a 15 times greater risk of developing 
sporadic Alzheimer’s disease than someone without this form of the APO E gene. 
Consequently, in Alzheimer’s patients, carriers of the APO E4 are common, with this allele 
being present in approximately 40 percent. 32 
 
The Cholinergic System  
 
Many of the cognitive deficits seen in Alzheimer’s disease seem linked to problems in 
the cholinergic system, Choline acetyltransferase is reduced, especially in the temporal cortex 
and the hippocampus. In addition, Alzheimer’s affected brains, again in their cortical and 
hippocampal areas, show a marked decrease in forebrain cholinergic neurons. Concentrations 
of cerebrospinal fluid acetylcholine are also low in Alzheimer’s disease patients and are 
positively correlated with dementia scale test scores. All this evidence, combined with studies 
show that anticholinergic drugs cause a decline in memory, which support the view that many 
of the cognitive deficits that occur in Alzheimer’s disease patients are probably caused by 
cholinergic abnormalities.33 
It has been the prevailing view that the symptomatic efficacy of AChEIs is attained 
through their augmentation of acetylcholine-mediated neuron-to-neuron transmission. 
However, there is evidence that AChEIs may slow disease progression and hippocampal 
atrophy and may have disease modifying effects. In addition, symptomatic improvement in 
AD patients is not restricted to agents that enhance acetylcholine function in the brain, as is 
the case for memantine which acts on another neurotransmitter. Interestingly, memantine, 
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whose benefits also appear to be best for moderate-to-severe AD, has been recently linked to 
modulation of inflammation also.34 
THE CATECHOLAMINERGIC  
The neurotransmitters of the nervous system dopamine and serotonin  can be derived 
from the amino acid tyrosine. The enzyme tetrahydrobiopterin, required for the synthesis of 
these two neurotransmitters, is significantly depressed in the cerebrospinal fluid of patients 
suffering from Alzheimer’s disease.  
It is not surprising, therefore, that the brains of patients with this type of dementia 
contain less dopamine and serotonin than usual. Several studies have demonstrated that the 
subnormal production of these neurotransmitters appears to be linked to the death of 
dopamine receptors and noradrenergic and serotonergic neurons, in the cortex and elsewhere 
in the Alzheimer’s brain. 35 
The loss of the D2 receptor-enriched modules in the brains of Alzheimer’s patients 
contributed to disturbances in information processing that may be responsible for cognitive 
and noncognitive impairments. Among the others, dopaminergic system may play a relevant 
role in the mechanisms involved in learning and memory processes, showing strong synaptic 
interaction with acetylcholine in different brain areas.36 
Most of the publications dealing with the role of serotonin receptors in AD focus on 
the possible interplay between the serotonergic system and the amyloid-mediated part of 
pathophysiology. This is mostly based on the experimental finding demonstrating that 
administration of selective serotonin reuptake inhibitors (SSRI) in mouse models of AD 
reduces the production of toxic amyloid proteins and amyloid plaques. The fact that SSRIs 
seem to inhibit the production of toxic amyloid species makes them a promising tool to slow-
down the progression of AD. Whereas serotonin receptors can influence processing of Aβ via 
modulation of activity of corresponding secretases , the role of serotonin receptors in NFT 
formation have not yet been analysed. However, there is indirect evidence suggesting the 
involvement of the serotonergic system in tau hyper-phosphorylation. 
An additional and even more intrigue connection between tau pathology and 5-HT 
receptors involves the receptor-mediated modulation of the Brain-derived neurotrophic factor 
(BDNF) concentration. It is known that BDNF attenuates tau and Aβ pathologies by 
activating the phosphatidylinositol 3 kinase/GSK-3β pathway. Activation of this pathway, 
which leads to the inhibition of GSK-3β activity, attenuates phosphorylation of tau and, 
consequently, reduces pathology 37 
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2.15 TREATMENTS 
Table 1: Pharmacological 38 
Generic Brand Approved for Side effects 
Donepezil Aricept All stages Nausea, vomiting, 
loss of appetite and 
increased frequency 
of bowel movements. 
galantamine Razadyne Mild to moderate Nausea, vomiting, 
loss of appetite and 
increased frequency 
of bowel movements. 
memantine Namenda Moderate to severe Headache, 
constipation, 
confusion and 
dizziness. 
rivastigmine Exelon Mild to moderate Nausea, vomiting, 
loss of appetite and 
increased frequency 
of bowel movements. 
memantine + 
donepezil 
Namzaric Moderate to severe Headache, diarrhea, 
dizziness, loss of 
appetite, vomiting, 
nausea, and bruising. 
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Table 2: Effect of Alzheimer’s drug 39 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Drug 
Slowing of 
cognitive 
decline 
Activities of 
daily living 
Overall risk of 
adverse events 
Stopped taking 
medication 
because of 
adverse effects 
Donepezil 
Very small 
effect 
Very small 
effect 
Upto 88% On average 19% 
Galantamine 
Very small 
effect 
Very small 
effect 
Upto 90% On average 17% 
Memantine 
Very small 
effect 
Very small 
effect 
Upto 84% Upto 10% 
Rivastigmine 
Very small 
effect 
Very small 
effect 
Upto 96% On average 24% 
Tacrine 
Data not 
reported 
Data not 
reported 
Upto 51% 
 
On average 43% 
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Table 3: New Medicines in Development for Alzheimer disease 39 
Drug name  Indication  Company  Development 
Status  
ABT-126 
acetylcholinesterase 
inhibitors  
 
Alzheimer disease  Abbott  Phase 2  
ABT-126  
 
Alzheimer disease  Abbott  Phase 2  
LY2886721  Alzheimer disease  Eli Lilly and 
Company  
Phase 1  
AZD3480  
 
Alzheimer disease  Targacept Inc.  Phase 2  
AVP-923 
(dextromethorphan/quinidine)  
 
Alzheimer disease, 
mild cognitive 
impairment  
Avanir 
Pharmaceuticals  
Phase 2  
MABT5102A  
 
Alzheimer disease  Genentech  Phase 2  
AZD5213  Alzheimer disease  AstraZeneca  Phase 2  
Gantenerumab Alzheimer disease  Hoffmann-La 
Roche  
Phase 3  
AAB-003 (PF-05236812)  
 
Alzheimer disease  Pfizer  Phase 1  
BMS-241027  Alzheimer disease  Bristol-Myers 
Squibb  
Phase 1  
MABT5102A  
 
Alzheimer disease  Genentech  Phase 2  
BIIB037  
 
 
Alzheimer disease 
prodromal or mild 
AD  
Biogen Idec  Phase 1  
GSK2647544  Alzheimer disease,  GlaxoSmithKline  Phase 1  
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MEDICINAL HERBS TO TREAT ALZHEIMER40 
Centellaasiatica L. (Umbelliferae) 
Extract from the leaves of Gotu Kola (Centella asiatica) has been used as an 
alternative medicine for memory improvement in the Indian Ayurvedic system of medicine 
for a long time. 
 
Ginkgo biloba L. (Ginkgoaceae) 
Ginkgo Biloba is the best known herb for Alzheimer’s disease and its associated 
symptoms. In controlled clinical trials, using a placebo and control group, ginkgo 
bilobaextracts showed therapeutic benefits in Alzheimer’s, similar to prescription drugs such 
as Donepezil or Tactrin, with minimal undesirable side effects. 
 
Salvia officinalis (Lamiaceae) 
Sage as it is more commonly referred for Alzheimer’s disease treatment. It has been 
reported to assist the brain in the fight against AD. Sage contains the antioxidants carnosic 
acid and rosmarinic acid. These compounds are thought to protect the brain from oxidative 
damage. 
 
Curcuma longa L. (Zingiberaceae) 
Curcuma longa (Turmeric) has been used as a source of Curcumin 
(diferuloylmethane), an orange‑yellow component of turmeric or curry powder. Studies have 
proved that Curcumin has anti‑inflammatory and antioxidant activities, and it helps in 
combating Alzheimer’s Disease (AD). Regular consumption of this herb helps in keeping the 
mind balanced. The dose of curcumin can be reduced by making it to colon targeting. 
 
Matricariarecutita (Asteraceae) 
Matricariarecutita is said to stimulate the brain, dispel weariness, calm the nerves, 
counteract insomnia, aid in digestion, break up mucus in the throat and lungs, and aid the 
immune system. Chamomile can relieve anxiety, and in higher doses, leads to drowsiness, 
according to the University of Maryland Medical Center 
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Lipidium meyenii Walp (Brassicaceae) 
Lipidium meyenii, is known as Maca. Maca shows beneficial improvement in memory 
and learning. Black maca improves experimental memory impairment, induced by 
ovariectomy, due in part, to its antioxidant and AChE inhibitory activities. Results 
demonstrated that black maca can enhance learning and memory in OVX (ovariectomized) 
mice 
 
Commiphora whighitti (Burseraceae) 
Commiphora whighitti , a plant resin, contains the major constituent of guggulipid, 
which is guggulsterone. The guggulipid has been seen to be a potential cognitive enhancer for 
improvement of memory in scopolamine‑induced memory deficits  
 
Withania somnifera (Solanaceae) 
Active glycowithanolides of Withania somnifera (Ashawgandha) have a significant 
antioxidant function, which is accomplished by increasing the activities of superoxide 
dismutase, catalase, and glutathione peroxidase. Ashwagandhais also reported as a Nervine 
tonic that rejuvenates the cells and boosts energy.  
 
 
NONPHARMACOLOGY TREATMENT 41 
 
 Cognitive enhancement 
 Individual and group therapy 
 Regular appointments 
 Communication with family, caregivers 
 Environmental modification 
 Attention to safety 
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2.16. LITERATURE REVIEW OF ALZHEIMER’S DISEASE 
1.Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated 
rats generates hyperphosphorylated tau protein. 
Grünblatt E et. al .investigated that  the intracerebroventricular (icv) application of 
streptozotocin (STZ) in low dosage was used in 3-month-old rats to explore brain insulin 
system dysfunction. Three months following STZ icv treatment, the expression of insulin-1 
and -2 mRNA was significantly reduced to 11% in hippocampus and to 28% in frontoparietal 
cerebral cortex, respectively. . Insulin receptor (IR) mRNA expression decreased 
significantly in frontoparietal cerebral cortex and hippocampus (16% and 33% of control). 
These abnormalities may point to a complex brain insulin system dysfunction after STZ icv 
application, which may lead to an increase in hyperphosphorylated tau-protein concentration. 
Brain insulin system dysfunction is discussed as possible pathological core in the generation 
of hyperphosphorylated tau protein as a morphological marker of sporadic Alzheimer's 
disease. 42 
2. Changes in hippocampal synapses and learning-memory abilities in a streptozotocin-
treated rat model and intervention by using fasudil hydrochloride. 
 Hou Y et.al. elucidate the anti-dementia role of FH(Fasudil hydrochloride, which is a  Rho 
kinase inhibitor  used to treat neurological diseases)  in Alzheimer's disease. Twenty-four 
Sprague-Dawley rats were randomly divided into four groups: (1) sham-operated group 
(control), (2) sham-operated followed by FH administration group (sham+FH), (3) 
streptozotocin (STZ)-treated group (STZ), and (4) STZ treatment followed by FH 
administration group (STZ+FH). The results indicate that STZ induced deficit in 
learning/memory, decrease in SYP expression, degeneration in synaptic structures, and 
increase in the expressions of p-LIMK2 and p-cofilin. These changes were reversed by the 
administration of FH, suggesting that FH has anti-dementia properties that protect synaptic 
structure and function. FH induced dephosphorylation (inactivation) of LIMK2 and 
subsequent dephosphorylation (activation) of cofilin, which may be responsible for the 
amelioration of neuronal synaptic structure and function.43 
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3.Long-term abnormalities in brain glucose/energy metabolism after inhibition of the 
neuronal insulin receptor: implication of tau-protein. 
 Hoyer S et.al. stated  that the triplicate intracerebroventricular (icv) application of the 
diabetogenic compound streptozotocin (STZ) in low dosage was used in 1-year-old male 
Wistar rats to induce a damage of the neuronal insulin signal transduction (IST) system and 
to investigate the activities of hexokinase (HK), phosphofructokinase (PFK), glyceraldehyde-
3-phosphate dehydrogenase (GDH), pyruvate kinase (PK), lactate dehydrogenase (LDH) and 
alpha-ketoglutarate dehydrogenase (alpha-KGDH) in frontoparietotemporal brain cortex (ct) 
and hippocampus (h) 9 weeks after damage.  In parallel, the concentrations of adenosine 
triphosphate (ATP), adenosine diphosphate (ADP), guanosine triphosphate (GTP) and 
creatine phosphate (CrP) were determined. The fall of the activities of the glycolytic enzymes 
HK, PFK, GDH and PK was found to be more marked after 9 weeks of damage when 
compared with 3- and 6-week damage whereas the diminution in the concentration of energy 
rich compound was stably reduced by between 20 and 10% relative to control. The 
abnormalities in glucose/energy metabolism were discussed in relation to tau-protein 
mismetabolism of experimental animals, and of sporadic AD.44 
4.Spatial discrimination learning and choline acetyltransferase activity in 
streptozotocin-treated rats: effects of chronic treatment with acetyl-L-carnitin 
Prickaerts J et.al. studied the effects of chronic treatment with ALCAR  on spatial 
discrimination learning in the Morris task and choline acetyltransferase (ChAT) activity of 
middle-aged STREP-treated rats. Chronic treatment with ALCAR attenuated both the 
STREP-induced impairment in spatial bias and the decrease in hippocampal ChAT activity. 
These findings indicate that ALCAR treatment has a neuroprotective effect, although further 
studies are needed to characterize the mechanism of action of ALCAR in this model.45 
5. Cognitive performance and biochemical markers in septum, hippocampus and 
striatum of rats after an i.c.v. injection of streptozotocin: a correlation analysis 
Fahrig T et.al evaluated the effects of an intracerebroventricular injection of streptozotocin 
on cognitive behavior and biochemical markers in the brain of middle-aged Wistar rats. 
Intracerebroventricular injected streptozotocin has previously been reported to decrease the 
central metabolism of glucose. They found that streptozotocin treated rats showed an 
impaired cognitive performance in the delayed non-matching to position task and the Morris 
water escape task. Glial fibrillary acidic protein, an indicator of reactive astroglial changes, 
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was measured in three different (soluble, Triton X-100 soluble and crude cytoskeletal) 
protein fractions and its content in the fractions of the septum, hippocampus and striatum of 
streptozotocin-treated rats was increased.46  
6. Tau Is Hyperphosphorylated at Multiple Sites in Mouse Brain In Vivo After 
Streptozotocin-Induced Insulin Deficiency 
Buffie J Clodfelder-Miller et.al  tested the hypothesis that insulin depletion caused by 
administration of streptozotocin may cause tau hyperphosphorylation in mouse brain by using 
site-specific phosphorylation-dependent tau antibodies to obtain precise identification of the 
phosphorylation of tau on individual residues. A massive (fivefold average increase) and 
widespread at multiple residues (detected with eight different phosphorylation-dependent tau 
antibodies) increase in the phosphorylation of tau was found in mouse cerebral cortex and 
hippocampus within 3 days of insulin depletion by streptozotocin treatment. This 
hyperphosphorylation of tau at some sites was rapidly reversible by peripheral insulin 
administration.47 
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2.17 GENERAL METHODS OF ALZHEIMER’S INDUCTION 
Aβ1-40, aluminium and growth factor β1 induced alzheimer’s 
A new animal model of AD was establish by stereotaxically injecting Aβ1-40, 
aluminium and growth factor β1 into lateral cerebral ventricle, and transforming growth 
factor β1 into anterodorsal nucleus of thalamus at the same time. This was  ideal animal 
model of AD that more mimic the complicated etiology, the praxiological features, 
pathological features and biochemistry changes of AD.  The results showed that the cognitive 
ability of the model rats was damaged, neurons became derangement and karyopyknosis, 
moreover, senile plaques ( SP ) and neurofibrillary tangles ( NFTs ) were found in the cortex 
and hippocampus over 3 months, choline acetyl transferase was decreased, and Aβ was 
increased.48 
AluminiumTrichloride Induced Alzheimer’s  
 
Different doses of AlCl3.6H2O (50, 70 and 100 mg/kg I.P ) were used. The 
progression of AD was also determined for all used dose levels of AlCl3 after different 
periods (4, 5 and 6 weeks), as well as after one week of stopping ALCL3 injection (70 and 50 
mg/kg I.P for 6 weeks) .t he present results showed that rats injected with AlCl3.6H2O at 
dose 70 mg/ kg I.P for 6 weeks represent the most exact model that mimics AD where the 
hippocampus neuronal degeneration and pyknosis were more pronounced he present results 
showed that rats injected with AlCl3.6H2O at dose 70 mg/ kg I.P for 6 weeks represent the 
most exact model that mimics AD where the hippocampus neuronal degeneration and 
pyknosis were more pronounced.49 
 
Beta Amyloid Induced Alzheimer’s  
Administration of beta amyloid (25-35) 10µl by intra cerebral ventricle results in 
development alzheimer’s. it causes accumulation of  beta amyloid in brain leads to neuronal 
degeneration. Histopathology examination shows formation tangles and plaques in 
hippocampus.50 
Colchicine Induced Alzheimer’s 
Colchicine is a microtubule-disrupting agent that produces marked destruction of 
hippocampal granule cells, mossy fibers and septo-hippocampal pathways. It induces 
neurofibrillary degeneration by binding to tubulin, the structural protein of the microtubule, 
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which is associated with loss of cholinergic neurons and decrease in acetylcholine 
transferase, thereby, resulting in impairment of learning and memory. Colchicine 7.5 µg in 
5µl in ACSF is used to induce Alzheimer’s. 51 
 
Streptozotocin induced alzheimer’s 
Streptozotocin (STZ) is a glucosamine-nitrosourea compound which was originally 
identified as an antibiotic. It is toxic to beta cells of pancreas and usually transported through 
glucose transporter 2 and commonly used to induce experimental diabetes in animals. STZ 
administration through route such as intra cebroventricular or intra peritoneal injection 
produces reduced cognition and increased cerebral aggregated Aβ fragments, total tau 
protein, and Aβ deposits. These changes were accompanied with decreased glycogen 
synthase kinase (GSK-3) alpha/beta ratio phosphorylated total in the brain. Administration of 
STZ in a rodent's brain has been shown to produce neuro inflammation, oxidative stress and 
biochemical alterations, which is considered to be a valid experimental model of the early 
pathophysiological changes in neurodegenerative disease. 52 
 
Transgenic mouse model for alzheimer’s 
Alzheimer’s can be induced by altering the genes in mouse. Genes that are 
responsible for amyloid, tau ,presenilin,  cholinergic pathways were identified and altered to 
induce alzheimer’s. 53 
Amyloid – TGF (transgene) 
Presenilin – Ps (transgene) 
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2.18 STREPTOZOTOCIN 
Streptozotocin(2-deoxy-2-(3-(methyl-3-nitrosoureido)-D-glucopyranose)) is a betacytotoxic 
drug which, following peripheral (parenteral) administration at high doses, selectively 
destroys insulin producing/secreting β cells in the pancreas, and causes type I diabetes 
mellitus in adult animals.54 
 
STZ mechanism of action 
Central mechanism of action of streptozotocin 
Central STZ administration caused neither systemic metabolic changes nor diabetes 
mellitus. STZ has been administrated mostly in doses ranging from 1–3 mg/kg body weight, 
injected 1–3 times, either uni-or bi-laterally into the lateral cerebral ventricles. The 
mechanism of central STZ action and its target cells/molecules have not yet been clarified but 
a similar mechanism of action to that in the periphery has been recently suggested. GLUT2 
may also be responsible for the STZ induced effects in the brain. So the changes were 
accompanied with decreased glycogen synthase kinase (GSK-3) alpha/beta ratio 
phosphorylated/total) in the brain. Administration of STZ in a rodent's brain has been shown 
to produce neuro inflammation, oxidative stress and biochemical alterations, which is 
considered to be a valid experimental model of the early pathophysiological changes in 
neurodegenerative disease. 52  
 
Peripheral mechanism of streptozotocin  
In the periphery, STZ causes selective pancreatic β cell toxicity results from the 
drug’s chemical structure which allows it to enter the cell via the GLUT2 glucose transporter. 
The predominant site of GLUT2 localization is the pancreatic beta cell membrane. Following 
peripheral administration, STZ causes alkylation of β -cell DNA which triggers activation of 
poly ADP-ribosylation, leading to depletion of cellular NADH and ATP). When applied intra 
peritoneally in high doses (45-75 mg/kg) STZ is toxic for insulin producing/secreting cells, 
which induces experimental DM type 1. Low doses (20-60 mg/kg) of STZ given intra 
peritoneally in neonatal rats damages IR and alters IR signaling and causes diabetes mellitus 
type. 55 
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Fig 5 : Mechanism of STZ in induction of  Alzheimer’s 
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FIG 6 : Mechanism of STZ in Cognitive dysfunction 
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STZ mediated neuroinflammation: 
 Neuroinflammation is a important pathology of AD and precedes plaque and tangle 
formation during AD progression.. There is a close association of neuro inflammation with 
the pathogenesis of AD and involves the activation of glial cells in neurodegenerative 
diseases such as AD . STZ treatment caused enhanced neuro inflammatory mediators and 
altered redox stress that contribute to the neurodegenerative processes. These free radicals 
also further trigger the neuronal damage via formation of pro-inflammatory mediators and 
associated cytotoxic products during neuro inflammation that can be detrimental to neuronal 
function. Reposts suggested that neuronal insulin protects from neuro inflammation and 
redox stress thus any impaired insulin function in brain hamper neuronal function. 52 
Neuroprotective role of insulin in brain:  
Interestingly, insulin can directly modulate synaptic plasticity and learning and 
memory, and disturbances in insulin signaling pathways in the periphery and in the brain 
have recently been implicated in AD and aging brain. Insulin also negatively regulates the 
metabolism of Aβ and tau proteins which are key building blocks of amyloid plaques and 
neurofibrillary tangles, and are well documented neuropathological hallmarks of AD. These 
negative regulations by insulin lead to more devastating for neurological function. 
Conversely, insulin injected into the brain intracerebroventricularly can improve performance 
of memory tasks in animals .Also, insulin delivered intranasally increased the performance of 
attention-related tasks in humans . A recent study reported that insulin receptor levels are 
down-regulated in the brains of AD patients . Insulin receptors were found to be internalized 
in neurons, and both insulin receptors (IRs)-1 and IRS-2 were reduced which taken together 
leads to reduced insulin signaling activity. It is becoming increasingly apparent that alteration 
of signaling molecules that are known to be involved in insulin signal transduction may play 
a role in the pathogenesis of AD .Although the actions of brain insulin are not fully 
understood 
, binding of insulin to its receptor initiates autophosphorylation of the receptor's β-
subunit, leading to binding and tyrosine phosphorylation of multiple insulin receptor 
substrates including IRS-1 and IRS-2, which play a role in synaptic plasticity and memory 
formation.52 
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3.PLANT PROFILE 
Botanical classification 56 
Kingdom - Plantae 
Phylum - Tracheophyta 
Class   - Liliopsida 
Order   - Arecales 
Family  - Arecaceae 
Genus  - Caryota 
Species - C.urens 
 
 
        FIG 7 :     Whole Tree                                                 Flowering Bud 
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3.1 BOTANIC DESCRIPTION  
Caryota urens is an unarmed, hapaxanthic, solitary or clustered, medium sized palm 
up to 20 m tall;  straight, unbranched, obscured at first by persistent fibrous leaf bases and 
sheaths, conspicuously ringed with narrow leaf scars, internodes elongated. Leaves bipinnate 
(pinnate in juveniles), induplicate with a terminal leaflet; sheath triangular, disintegrating into 
strong black fibres, densely hairy;petiolechannelled above; leaflets numerous, obliquely 
wedge shaped, upper margin irregularly toothed. Inflorescence axillary, solitary, pendulous, 
branched to 1 order or rarely unbranched, bisexual; prophyll tubular; peduncular bracts up to 
8, large; distal portion of rachis bearing spirally arranged, protandrous triads of 2 male 
flowers and 1 female flower. Flowers with 3 sepals and 3 petals.Male flower with free petals; 
stamens 6, filaments short, sometimes connate at base. Female flower globose; petals connate 
up to half way; ovary superior, 3-locular with a single ovule per cell, stigma 3-lobed.The 
smooth epicarp of the drupaceous and globose fruit turns dark scarletred at maturity. 
Mesocarp is fleshy, filled with abundant, irritant, needlelike crystals. The endocarp is not 
differentiated. Each fruit has 2 large hemispherical seeds with ruminate endosperm.57 
 
Distribution  
Native   - India, Malaysia, Myanmar, Nepal, Sri Lanka 
Exotic    - Papua New Guinea, Thailand, Vietnam 
 Other names: 
Bengali   -  sopari 
English  - fishtail palm, Indian sago palm, wine palm, jaggery  palm, kitul palm   
Hindi   - mari 
Sanskrit  - mada, dirgha 
Sinhala  - kitul 
Tamil   - kundalpanai, koondalpanai, thippali, tippili, kondapanna 
 
Uses 
It is used to treat gastric ulcers, migraine headaches, snake-bite poisoning and rheumatic 
swellings. The root is used for tooth ailments, the bark and seed to treat boils, and the tender 
flowers for promoting hair growth. 57 
Ameriolative Effect Of Hydro Alcoholic Extract Of Caryota urens STZ Induced Alzheimer’s  
 
Department of Pharmacology Page 42 
 
3.2 PLANT LITERATURE REVIEW 
Evaluation Of Central Nervous System Activity Of Caryota urens Fruit Extract On 
Various Animal Models  
Murshid .V, studied  the influence of Caryota urens  on various CNS disorders like 
epilepsy, depression, anxiety, neuralgia, motor in coordination,  motility using experimental 
models. This study demonstrared the extract of Caryota urens may be helpful in protecting 
effects in CNS disorders.58 
Antioxidant Activity of Caryota urensL. (Kithul) Sap 
 P. Ranasingheet. alstudied  the antioxidant properties of C.urens sap, using 1,1-
diphenyl-2-picryl-hydrazyl (DPPH), 2,2-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) 
(ABTS+), Ferric Reducing Antioxidant Power (FRAP) and metal ion chelating assays. 
Radical scavenging activity and FRAP value were calculated. This study shows, for the first 
time, antioxidant activity of C. urens sap, as determined by free radical scavenging activity, 
electron donating reducing power and metal ion chelating capacity.59 
Antioxidant and anti-diabetic properties of Caryota urens (Kithul) flour 
 
G. E. M. Wimalasiri et.al studied the  antioxidant properties of C. urens flour  using 
different in vitro assays namely, 2,2-azino-bis 3-ethylbenzothiazoline-6-sulfonic acid 
(ABTS+), ferric reducing antioxidant power, oxygen radical absorbance capacity and ferrous 
ion chelating assays. Total phenolic Content (TPC) and Total flavonoid Content (TFC) were 
also evaluated. Anti-diabetic properties were estimated using alpha amylase and alpha 
glucosidase enzyme inhibition assays. He concluded from results that Caryota urens flour has 
moderate antioxidant property but did not contain any marked anti-diabetic properties.60 
 
Qualitative phytochemical screening, anti-oxidant and anti-microbial activity studies on 
ethanolic flowers extract of caryota urenes linn.  
A.Charles et.al studied the anti-oxidant activity of C.urens flowers on DPPH, 
Hydrogen per-oxide, and reducing power scavenging activity methods. This study also 
includes antimicrobial activity using 20 bacterial species and 7 fungal species. The results 
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describes promising antioxidant property of C.urens and the zone of inhibition concentration 
of bacteria and fungus was found to be 25μg/25μl.61 
Phytochemical analysis on Caryota urens (fishtail palm) fruit from VIT university 
campus for pharmaceutical use 
 
Vaishnavi R et.al studied the phytochemical analysis on C.urens. The results shows 
the presence of carbohydrate, alkaloids, flavanoids and phenols, organic and inorganic 
nature.62 
 
Chemical Constituents from the Base Leaves of Caryota urens 
Hasan M.H. Muhaisen isolated the chemical constitutens from base leaves of the 
plant. The results shows the presence of following compounds Triacontane, Lupeol, 
Myricadiol ,Sitosterol, Tetracosonid, Ursolic acid. 63 
Identification of Flavonoids in Methanolic Extract of Caryota urens (Fish Tail Palm): A 
Phytochemical Screening Involving Structure Analysis by FTIR Spectroscopy 
 
V. Devi Rajeswari et.al. This study involves isolation of flavonoids from Caryota 
urens using thin layer and high performance liquid chromatography. Isolated compounds 
were subjected to NMR and FTIR spectroscopy, The different frequencies of the peaks in 
FTIR spectrum is found to fall in the same range of frequencies of functional groups which is 
present in rutin.64 
In Vitro Estimation Of Antioxidant Activity Of Caryota urens Fruits 
 
Md. SahabUddin studied the antioxidant activity of chloroform fraction (CLF), carbon 
tetra chloride fraction (CTF) and n-Hexane fraction (NHF) of methanolic extracts of Caryota 
urens (CU) fruits, using DPPH (2,2‑diphenyl‑2‑picrylhydrazyl) radical scavenging assay 
from the results he concluded among three different fractions CLF showed the highest 
antioxidant activity (61.58 % scavenging) at 400 μg/ml concentration followed by CTF and 
NHF. The IC50 values for the DPPH radical scavenging test were in the order of CLF (93.45 
± 3.09 μg/ml) > CTF (473.01 ± 12.95) > NHF (613.13 ± 7.64). This study suggested that 
CLF of CU fruits had strong antioxidant effect compared to CTF and NHF. 65 
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4. SCOPE OF THE WORK 
Alzheimer's disease (AD) is a neurodenerative disorder that gradually impairs 
memory and ability to learn, reasoning, judgment, communication and daily activities. AD is 
characterized clinically by cognitive and memory impairment. An estimated 5.4 million 
Americans of all ages have Alzheimer's disease in 2016.Of the 5.4 million Americans with 
Alzheimer's, an estimated 5.2 million people are age 65 and older. By 2050, the number of 
people age 65 and older with Alzheimer's disease may nearly triple, from 5.2 million to a 
projected 13.8 million. 
There is currently no cure for Alzheimer’s disease. But currently some category of 
drugs like AChE inhibitors and NMDA antagonists were used along with some antioxidants 
and some other supportive therapy. Therefore there is a lot of promising scope in the 
development of drug therapy for this serious and debilitating disorder.  
Since ancient time the herbal medicines are effective in the treatment of various 
ailment, many plants have been used in the treatment of several dreadful disease but they are 
not scientifically exploited or improperly used. Therefore, these plant drugs deserve detailed 
studies in the light of modern science. 
The present study is to prove the memory enhancement and cognitive effect of 
caryota urens on  Alzheimer’s  induced mice using various memory retention experiments 
such as Y maze , Morris water maze, Passive avoidance etc. 
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5. PLAN OF WORK 
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6. MATERIALS AND METHODS 
 
6.1 Collection and authentication: 
 
The fresh flowering bud of  plant of crayota urens (Arecaceae) was collected from 
kelambakkam, chennai district of Tamilnadu in the month of December. The plant material 
was identified and authenticated by Dr.D.Aravind, Assistant Professor, specialization in 
medicinal plants, Department of Botany, National Institute Of Siddha, Ministry of AYUSH 
(Govt.Of India), and Chennai-47.A voucher specimen was submitted at C.L.BaidMetha 
college of pharmacy, Chennai-97. 
 
6.2 Preparation of hydroalcohlic extract of Caryota urens (HAECU) 
 
The fresh flowering bud of plant of crayota urens was collected and washed with 
running water. It was shade dried at room temperature and that dried plant material was made 
into coarse powder. The powder was extracted with ethanol (70%) and water 30%) in soxhlet 
extractor. 
 
6.3 Method of extraction  
 
The extraction was carried out in Soxhlet apparatus. The coarse powder weighing 
200g was extracted with ethanol in water bath at room temperature for 72 hours. The solvent 
was then removed by filtration and fresh solvent was added to the plant material. The extract 
process was twice repeated. The combined filtrates were then evaporated under reduced 
pressure to give dark green viscous mass. The extract was stored at 0-4°C. 
 
6.4. Percentage yield: 
 
The hydroalcoholic extract yielded dark greenish  brown semisolid residues, and percentage 
yield was found to be (15 %w/v) and the extract was preserved by refrigeration for further 
use. 
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Table 4: CHEMICALS USED 
S.no Chemicals Name Company Name 
1.  5,5-Dithio-bis-2-nitro benzic acid (DTNB) Ellman’s 
reagent 
Sisco Research  
Laboratories 
pvt. Ltd, Mumbai 
2.  Acetic acid S.D. Fine-Chem Ltd, Mumbai 
3.  Acetylthiocholine iodide S.D. Fine-Chem Ltd, Mumbai 
4.  Acetylthiocholine esterase SRL chemicals, sisco lab, Maharastra. 
5.  Carboxy methl cellulose LobaChemie Pvt. Ltd,  Mumbai 
6.  Chloroform LobaChemie Pvt. Ltd, 
 Mumbai 
7.  Distilled water Andavar Distilled Water Company, Chennai 
8.  Disodium Dihydrogen Phosphate LobaChemie Pvt. Ltd, 
 Mumbai 
9.  Donepezil Eisai Pharmaceuticals,  Mumbai 
10.  Ethyl acetate 
Ranbaxy Fine Chemical  
Ltd, 
NewDelhi 
11.  Ethylene diamine tetra acetic acid (EDTA) Disodium Salt Chemspure, Chennai 
12.  Ethanol LobaChemie Pvt. Ltd,  Mumbai 
13.  Formalin Paxy speciality chemicals, Chennai 
14.  Glutathione oxidased SRL chemicals, sisco lab, Maharastra 
15.  Glutathione  reduced (GSH) SRL chemicals, sisco lab, Maharastra 
16.  Hydrogen peroxide Chemspure, Chennai 
17.  Hydrochloric acid LobaChemie Pvt. Ltd,  Mumbai 
18.  Magnesium chloride LobaChemie Pvt. Ltd,  Mumbai 
19.  Perchloric acid LobaChemicals Pvt Lyd Mumbai 
20.  Potassium chloride Chemspure, Chennai 
21.  Pyridine Merck Specialties Pvt Ltd 
22.  Sodium Azide SRL Chemicals, Maharastra 
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23.  Sodium dodoecyl sulphate S.D fine Chemicals 
,Mumbai 
24.  Sodium hydroxide Chem pure , Chennai 
25.  Sodium bicarbonate S.D fine Chemicals, Mumbai 
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7. PRELIMINARY PHYTOCHEMICAL ANALYSIS 66 
                 The Hydro-alcoholic extract of Caryota urens was subjected to preliminary 
phytochemical screening for the presence or absence of phytoconstituents by the following 
methods.    
1) Test for alkaloids:  
The extract was treated with dilute hydrochloric acid and filtered. The filtrate is used in the 
following tests.   
a) Mayer’s reagent (Potassium Mercuric Iodine Solution)  
0.5ml of the extract was treated with Mayer’s reagent and the appearance of cream color 
indicates the presence of alkaloid 
b) Dragendroff’s test (Potassium Bismuth Iodide)  
0.5ml of the extract was treated with Dragendroff’s reagent and the appearance of reddish 
brown color precipitate indicates the presence of alkaloid.  
c) Hager’s test (Saturated solution of Picric acid)  
0.5ml of the extract was treated with Hager’s test and the appearance of yellow color 
precipitate indicates the presence of alkaloid.  
d) Wagner’s test (Iodine-Potassium Iodide Solution)  
0.5ml of the extract was treated with Wagner’s test and the appearance of brown color 
precipitate indicates the presence of alkaloid.   
2) Test for Carbohydrates   
a) Molisch’s test:  
The extract was treated with 3ml of alpha-napthol in alcohol and concentrated sulphuric acid 
was added along the sides of the test tube carefully. Formation of violet color ring at the 
junction of two liquids indicates the presence of carbohydrates.      
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b) Fehling’s test (CuSO4.7H2O+KOH+Potassium Tartarate): 
The extract was treated with Fehling’s solution A and B heated in boiling water for few 
minutes. The appearance of reddish brown color precipitate indicates the presence of 
reducing sugars.  
c) Benedict’s test (Sodium citrate + sodium carbonate + CuSO4.7H2O) 
The extract was treated with Benedict’s test and heated in boiling water for few minutes. The 
appearance of reddish orange color precipitate indicates the presence of reducing sugars.  
d) Barfoed’s test (Copper Acetate+ Glacial acetic acid) 
The extract was treated with Barfoed’s test and heated in boiling water for few minutes. The 
appearance of reddish orange color precipitate indicates the presence of non- reducing sugars.   
3)Test for steroids  
a) LibermannBurchard test:  
 The extract was treated with small quantity of concentrated sulphuric acid, glacial acetic acid 
and acetic anhydride. The appearance of green color indicates the presence of steroids   
4) Test for proteins  
a) Biuret’s test: 
The extract was treated with copper sulphate and sodium hydroxide solution. The appearance 
of violet color indicates the presence of proteins.  
b) Millon’s test: 
The extract was treated with Millon’s reagent. The appearance of pink color indicates the 
presence of proteins.  
5) Test for Tannin’s  
a) The extract was treated with 10% lead acetate solution. The appearance of white 
precipitate indicates the presence of tannins.  
b) The extract was treated with aqueous bromine solution. The appearance of white 
precipitate indicates the presence of tannins.   
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6) Test for Phenols  
a) The extract was treated with neutral ferric chloride solution. The appearance of violet 
indicates the presence of phenols.  
b) The extract was treated with 10% sodium chloride solution. The appearance of cream color 
indicates the presence of phenols.  
7) Test for Flavonoid’s  
a) 5ml of extract solution was hydrolysed with 10%v/v sulphuric acid and cooled. Then, it is 
extracted with diethyl ether and divided into three portions in three separate test tubes. 1ml of 
diluted sodium carbonate, 1ml of 0.1N sodium hydroxide, and 1ml of strong ammonia 
solution were added to the first, second and third test tubes respectively. In each test tube, 
development of yellow color demonstrated the presence of flavonoids.  
b) Shinoda’s test: The extracts were dissolved in alcohol, to that one piece of magnesium is 
added followed by concentrated hydrochloric acid along the sides of the test tube drop wise. 
It is heated in a boiling water bath for few minutes. The appearance of magenta colour 
indicates the presence of flavonoids.  
8) Test for Gums and Mucilage 
The extract was treated with 25ml of absolute alcohol and then solution was filtered. The 
filtrate was examined for its swelling properties.       
9) Test for Glycosides 
The extract was dissolved in the glacial acetic acid and few drops of ferric chloride solution 
was added, followed by the addition of concentrated sulphuric acid, formation of red ring at 
the junction of two liquids indicates the presence of glycosides.   
10) Test for Saponins 
           1ml of the extract was diluted to 20ml with distilled water and shaken well in a test 
tube. The formation of foam in the upper part of the test tube indicates the presence of 
saponins.   
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11) Test for Terpenes 
The extract was treated with tin and thionyl chloride, appearance of pink color indicates the 
presence of terpenes.   
12) Test for sterols 
The extract was treated with 5% potassium hydroxide solution; appearance of pink color 
indicates the presence of sterols.   
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8. ACUTE TOXICITY STUDIES 67 
   The acute toxicity was done by using OECD guidelines 423.The acute toxic class 
method (423) was step wise procedure with 3 animals of single sex per step. Depending on 
the mortality and/or morbidity status of the animals, on the average 2-4 steps may be 
necessary to allow judgment on the acute toxicity of the substances. This procedure results in 
the use of a specified number of animals while allowing for acceptable data- based scientific 
conclusion.   
This method uses defined doses of drug (2000mg/kg body weight) and results allow a 
substance to be ranked and classified according to the Globally Harmonized System (GHS) 
for classification of chemical which cause acute toxicity.   
Procedure:  
Adult female Swiss albino mice weighing 20- 30gms were used for the study. The 
starting dose level of 2000mg/kg body weight p.o of hydro-alcoholic extract Caryota urens 
was given. Since most of the crude extracts possess LD50 value more than 2000 mg/kg, p.o. 
so starting dose 2000mg/g p.o. was used. Dose volume administered was 1ml/100 gm body 
weight to mice which were fasted overnight with water ad libitum. Food was withheld for 
further 3-4hrs after oral administration of drugs and observed for the signs of toxicity.    
Body weight of mice before and after determination were noted and any changes in 
skin and fur, eyes and mucous membrane, respiratory, circulatory, autonomic & central 
nervous system, motor activity and behavior pattern were observed and also sign of tremors, 
convulsion, salivation, diarrhoea, lethargy, sleep and coma were noted. The onset of toxicity 
and signs of toxicity also noted. 
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9. EXPERIMENTAL ANIMALS: 
 
The Swiss albino mice weighing 22-30gm were used for this study. The inbreed 
animals were procured from the animal house of C.L.BaidMetha college of pharmacy, 
Thoraipakkam, Chennai- 97.They were housed six per kg under standard laboratory 
conditions at a temperature 22±2°C with 12:12 hrs light and dark circle. The animals were 
provided with standard animal feed, water and ad libitum. The animals were adapted to 
laboratory conditions one week prior to initiation of experiments. All experiments were 
carried out according to the guidelines for care and use of experimental animals and approved 
by Committee for the Purpose of Control and Supervision of Experiments on Animals 
(CPCSEA ). The study was approved by Institutional Animal Ethical Committee (IAEC) 
 
9.1 EXPERIMENTAL DESIGN:  
 
On the first day of experiment the animals were divided randomly into five groups of 
six animals each. Amnesia is induced by i.c.v. of streptozotocin for the II, III, IV, V groups 
were performed on the 21st day of the pretreated animals and treatment was continued for 5 
days. Control animals were given 1%w/v of CMC orally by using intragastric catheter, were 
the last dose was given 60 min prior to behavioral testing and on 30th day scarification of 
animal were done for invitro studies. 68 
 
Experimental dementia of AD in mice was induced by i.c.v. STZ. Mice were anesthetised 
with anesthetic ether and i.c.v. injections were made with a hypodermic needle of 0.4 mm 
external diameter attached to a 10 μl Hamilton microlitre syringe. STZ was dissolved in 
freshly made ACSF (25 mg/ml) solution. (ACSF (147 mMNaCl; 2.9 mMKCl; 1.6 mM 
MgCl2, 1.7 mM dextrose)). 69 
 
 
IAEC REFERENCE NO: IAEC/XLVII02/CLBMCP/2015 
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GROUPING 
S.no Groups Treatment 
1 Group I Carboxy methyl cellulose(1%w/v)  p.o 
2 Group II 
Negative control 
Streptozotocin(2mg/kg,  i.c.v) 
3 Group III 
Standard 
Donepezil (5mg/kg, i.p.) 
4 Group IV Pretreatment with HAECU(200mg/kg,p.o) 
5 Group V Pretreatment with HAECU(400mg/kg,p.o) 
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10.METHODS AND ASSESSMENTS  
 
10.1 ASSESSMENT OF HABITUATION BEHAVIOUR 
 
10.1.1 Open field activity70 
Exploratory behavior was evaluated in an open field paradigm. The open field was 
made up of plywood and comprises of 40 x 50 x 60 cm dimension. The entire apparatus was 
painted black and divided into 16 squares with white lines on the floor. Each animal was 
placed at the corner of the apparatus and for next five minutes they were observed for their 
ambulation such as line crossings and head dipping. 
 
10.1.2 Closed field activity 71 
The locomotor activity was measured by using an Actophotometer. The 
actophotometer consisted of a square arena (30 x 30 x 25 cm) with wire mesh bottom, in 
which the animal moves. Six lights and six photocells were placed in the outer periphery of 
the bottom in such a way that a single mouse can block only one beam. The movement of the 
animal interrupts a beam of light falling on a photocell, at which a count was recorded and 
displayed digitally. The locomotor activity was measured for a period of 10minutes. 
Technically its principle is that, a photocell is activated when the rays of light falling on the 
photocell are cut off by animals crossing the beam of light. As the photocell activated, a 
count is recorded. The photocells are connected to an electronic automated counting device 
which counts the number of ―cut offs‖. 
 
 10.2 ASSESSMENT OF MEMORY AND RETENTION 
10.2.1 Morris water maze test 72- 73 
The Morris water maze test is performed to evaluate spatial working and reference 
memory. In this model the animals are placed into a large circular pool of water and they can 
escape on to a hidden platform. The platform is hidden by its placement just below the water 
surface and by opaque water. Therefore the platform offers no local cues to guide the escape 
behavior. The animal can escape from swimming by climbing on to the platform and with 
time the animal apparently learns the spatial location of the platform from any starting 
position at the circumference of the pool. Morris water maze consists of a large circular tank 
made of black opaque polyvinyl chloride or hardboard coated with fiber glass and resin and 
Ameriolative Effect Of Hydro Alcoholic Extract Of Caryota urens STZ Induced Alzheimer’s  
 
Department of Pharmacology Page 58 
 
then surface painted white (1.8-2m in diameter and 0.4-0.6m high). The pool is filled upto a 
height of 30cm with water maintained at around 25°C and rendered opaque by addition of 
small quantity of milk or non-toxic white color. The pool is provided with filling and draining 
facilities and is mounted at waist level. The tank is hypothetically divided into 4 equal 
quadrants the platform (11cm2 ) of 29 cm height is located in the centre of one of these 4 
quadrants. The platform remains fixed in the position during the training session. Each 
animal is subjected to four consecutive trials for four days (21-24) during which they are 
allowed to escape on the hidden platform and allowed to remain for 20seconds. Escape 
latency time to locate the hidden platform in water maze is noted as an index of acquisition or 
learning. In case the animal is unable to locate the hidden platform within 120seconds, it is 
gently guided by hand to the platform and allowed to remain there for 20seconds. On the 29th 
day, 60minutes after last dose, platform is removed and time spent by each animal in target 
quadrant searching for the hidden platform is noted as an index of retrieval and measured. 
 
 10.2.2 Passive Shock Avoidance Test: 74 
 
Passive avoidance behavior based on negative reinforcement was used to examine the 
long term memory. The apparatus consisted of a box (27x27x27 cm) having three walls of 
wood and one wall of Plexiglass,featuring a grid floor (3mm stainless steel rods set 8mm 
apart) with a wooden platform (10x7x1.7cm) in the centre of the grid floor. Electric shock 
(20V,A/C) was delivered to the grid floor. During training session ,each mouse was gently 
placed on the wooden platform set in the centre of the grid floor, when the mouse stepped 
down and placed all its paw on the grid floor, shocks were delivered for 15seconds and the 
Step Down Latency(SDL) was recorded. SDL was defined as time taken by the mouse to step 
down from the wooden platform to grid floor with its entire paw on the grid floor. Animals 
showing SDL in the range of 2 to 15 seconds during the first were used for the second session 
and the retention test. The second session was carried out 90minutes after the first test. 
During second session, if the animals stepped down before 60seconds, electric shocks were 
delivered once again for 15seconds. During the second test, animals were removed from 
shock free zone ,if they did nt step down for a period of 60seconds and subjected to retention 
test. On the 29th day, after the treatment of last dose training was given and memory 
retention was examined after 24 hours (i.e., on 30th day) in a similar manner, except that the 
electric shocks were not applied to the grid floor observing an upper cut off time of 300 
seconds. 
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10.2.3. Y Maze Test 75 
Immediate working memory performance was assessed by recording spontaneous 
alternationbehavior in a single session in a Y maze made up of black painted wood. Each arm 
was 40cmlong, 12cm high, 3cm wide at the bottom and 10cm wide at the top and converged 
in an equilateral triangular central area. Each mouse was placed at the end of one arm and 
allowed to move freely through the maze during an 8 minute session. The series of arm 
entries was recorded visually. Entry was considered to be complicated when the hind paws of 
the mouse had completely entered the arm. Alternation was defined as successive entries into 
the three different arms (A, B and C) on overlapping triplet sets. The percentage of traids in 
which all three arms were represented i.e, ABC, CAB or BCA but not BAB was not recorded 
as an ―alternation‖ to estimate short term memory. Percentage alternation was calculated as 
the ratio of actual to possible alternation (defined as the total number of arm entries minus 
two), multiplied by hundred as shown %alternation= {(No. of alternations) / (Total arm 
entries -2)} x 100. On the 29th day, 90 minutes after the treatment of last dose arm entries 
was recorded visually and percentage alternation was calculated. 
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11. NEUROTRANSMITTERS ESTIMATION  
11.1. Acetylcholinesterase(AChE) enzyme determination 76 
Acetylcholinesterase enzyme activity was estimated by Elman method. 
Reagents 
1. 0.1M phosphate buffer 
2. DTNB Reagent 
3. Acetylthiocholine (ATC) 
 
Procedure 
The mice were decapitated,brains are removed quickly and placed in ice cold saline. 
Frontal cortex, hippocampus and septum are quickly dissected out on a petri dish chilled on 
crushed ice.the tissues were weighed and homogenized in 0.1M phosphate buffer( pH 
8).0.4ml aliquot of the homogenate is added to a cuvette containing 2.6ml of phosphate 
buffer(0.1M,pH 8) and 100μl of DTNB. The contents of the cuvette are mixed thoroughly by 
bubbling air and absorbance is measured at 412nm in a spectrophotometer. When absorbance 
reaches a stable value,it is recorded as basal reading.20μl of substrate i.e., acetylthiocholine is 
added and change in absorbance is recorded. Change in absorbance/min is thus determined. 
 
 
 
 
 
 
 
 
 
 
 
 
Reagents Sample Blank 
Phosphate buffer solution 2.6ml 2.7ml 
Supernatant 0.4ml 0.4ml 
DTNB 0.1ml …… 
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Calculations 
The enzyme activity is also calculated by using the following formula 
                                                             A/min X Vt 
Acetylcholinesterase activity (M/ml) = ----------------------- 
ε X b X VS 
where, 
A/min= Change in absorbance per min 
ε= 1.361x 104 M/cm 
b= path length (1cm) 
Vt= total volume (3.1ml) 
VS= sample volume (0.4ml) 
The final reading of enzyme activity is expressed as μ moles/min/mg tissue 
μ moles/ml sample 
μ moles/min/mg protein= ------------------------------------------- 
mg protein/ml sample dilution 
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11.2. Estimation of dopamine 77 
 
Preparation of tissue extracts 
Reagents 
1. HCl-butanol 
2. Heptanes 
3. 0.1M HCl: (0.85ml conc. HClupto 100ml of water) 
 
Procedure 
On the day of experiment mice was sacrificed, whole brain was dissected out and the 
subcortical region (including the striatum) was separated. Weigh the tissue and homogenized 
in 5ml HCl-butanol for about 1 min. the sample was then centrifuged for about 10 min at 
2000rpm. An aliquot supernatant phase (1ml) was removed and added to centrifuge tube 
containing 2.5ml heptane and 0.31ml of 0.1M HCl. After 10 min of vigorous shaking , the 
tube was centrifuged under the same conditions as above in order to separate two phases, and 
the overlaying organic phase was discarded. The aqueous phase (0.2ml) was then either taken 
for the dopamine assay. All the steps were carried out at 0°C. it was taken in between 50-75 
mg of the tissue for homogenate with 5ml of HCl-butanol in correlation of same tissue 
concentration of 0.1ml of HCl-butanol in Schlumpf method. 
 
Reagents 
 
1. 0.4M HCl: 3.4ml conc. HClupto 100ml water 
 
2. Sodium acetate buffer pH(6.9)  
3. 5M NaOH:  
 
4. 0.1M Iodine solution( in ethanol) 
 
5. Sodiumthiosulphate 
 
6. 10M acetic acid: 57ml of glacial acetic acid dissolved in distilled water upto 100ml. 
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Procedure 
To the 0.2ml of aqueous phase, 0.5ml 0.4M HCl and 0.1ml of EDTA/sodium acetate 
buffer (pH6.9) were added, followed by 0.1ml iodine solution (0.1M in ethanol) in oxidation. 
The reaction was stopped after 2 min by addition of 0.1ml Sodium thiosulphate solution. 
0.1ml acetic acid is added after 1.5 min. the solution was then heated to 100°C for 6 min 
when the sample again reached room temperature, excitation and emission spectra were read 
from the spectrofluorimeter. The readings were taken at 330-370nm. 
 
  
 
Unknown conc  =  intensity of unknown * conc of std 
 intensity of std 
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11.3. Estimation of Serotonin 77 
 
The serotonin content was estimated by the method of Schlumpf. 
 
Reagents 
 
1. O-phthalaldialdehyde (OPT) reagent 
 
Procedure 
To 0.2ml of aqueous extract 0.25ml of OPT reagent was added. The flurophore was 
developed by heating to 100°C for 10 min. after the samples reached equilibrium with the 
ambient temperature, readings were taken at 360-470nm in the spectrofluroimeter. For 
serotonin tissue blank, 0.25ml conc. HCl without OPT was added. Internal standard: 500μg 
/ml each of noradrenaline, dopamine and serotonin are prepared in distilled water: HCl-
butanol in 1:2 ratios. 
 
 
Unknown conc  =  intensity of unknown * conc of std 
 intensity of std 
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12. Estimation of Antioxidant Enzyme 
12.1. Estimation of Superoxide dismutase (SOD) 78 
Reagents 
1. Carbonate buffer (100mM, pH 10.2) 
2. Epinephrine (3mM) 
Procedure 
The SOD activity in supernatant was measured by the method of Misra and Fridovich. 
The supernatant (500µl) was added to 0.800ml of carbonate buffer (100mM, pH 10.2) and 
100µl of epinephrine (3mM). The change in absorbance of each sample was then recorded at 
480nm in spectrophotometer for 2min at an interval of 15sec. Parallel blank and standard 
were run for determination of SOD activity. 
One unit of SOD is defined as the amount of enzyme required to produce 50% inhibition of 
epinephrine auto oxidation. 
 
Reagents Uninhibited (Standard) Inhibited (Sample) Blank 
Carbonate buffer 0.900ml 0.800ml 1.0ml 
Supernatant - 0.1ml - 
Epinephrine 0.1ml 0.1ml - 
 
The reaction mixtures are diluted 1/10 just before taking the readings in spectrophotometer 
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Calculation  
 
%𝐈ܖܐܑ܊ܑܜܑܗܖ =  ∆Aସ8଴୬୫ min⁄ Uninhibited − ∆Aସ8଴୬୫ min⁄ inhibited∆Aସ8଴୬୫ min⁄ Uninhibited − ∆Aସ8଴୬୫ min⁄  Blank  × ͳͲͲ 
 
𝐔ܖܑܜܛ  ܕܔ⁄ ܍ܖܢܡܕ܍ = %Inhibition ×  V୲ሺͷͲ%ሻ ×  Vୱ  
 𝐔ܖܑܜܛ ⁄ ܕ܏ ܘܚܗܜ܍ܑܖ =  Units  ml enzyme⁄mg protein ⁄ ml enzyme 
Where, 
Vt= Total volume (1.0ml) 
Vs= Sample volume (0.1ml) 
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12.2. Estimation of Catalase (CAT) 79 
Reagents 
a. Phosphate buffer solution (50mM) 
b. Hydrogen peroxide (H2O2) 30mM 
Procedure 
  Catalase activity was measured by the method of Aebi. 0.1ml of supernatant was 
added to cuvette containing 1.9ml of 50mM phosphate buffer (pH 7.0). Reaction was started 
by the addition of 1.0ml of freshly prepared 30mM H2O2. The rate of decomposition of H2O2 
was measured spectrophotometrically from changes in absorbance at 240nm. Activity of 
catalase was expressed as units/mg protein. A unit is defined as the velocity constant per 
second.  
Reagents Sample Blank 
Phosphate buffer 1.9ml 2.9ml 
Supernatant 0.1ml 0.1ml 
H2O2 1ml - 
The reaction occurs immediately after the addition of H2O2. 
Solutions are mixed well and the first absorbance (A1) is read after 15sec (t1) and the second 
absorbance (A1) after 30sec (t1). The absorbance is read at wavelength 240nm.  
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Calculation 
 
𝐊    =    V୲Vୱ    ×   ʹ.͵∆t   × log AଵAଶ   ×  ͸Ͳ 
 
Where,  
K =Rate constant of the reaction 
∆t = (t2-t1) = 15sec 
A1 = Absorbance after 15sec 
A2 = Absorbance after 30sec 
Vt = Total volume (3ml) 
Vs = Volume of the sample (0.1ml) 
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12.3. Estimation of Lipid peroxidase (LPO) 80 
The level of Lipid peroxidase was estimated by Thiobarbituric acid reaction method 
described by Ohkawaet al. 
Reagents 
1. Sodium dodecyl sulphate (SDS) (8.1% w/v) 
2. Acetic acid (20%; pH 3.5) 
3. Thiobarbituric acid (TBA) (0.8%) 
4. n-butanol/pyridine mixture (15:1) 
Procedure 
 To 0.2ml of test sample, 0.2ml of SDS, 1.5ml of acetic acid and 1.5ml of TBA were 
added. The mixture was made up to 4ml with water and then heated in a water bath at 95°C 
for 60min. After cooling, 1ml of water and 5ml of n-butanol/pyridine mixture were added and 
shaken vigorously. After centrifugation at 4000rpm for 10min, the organic layer was taken 
and its absorbance was read at 532nm. The level of lipid peroxides was expressed as nmoles 
of MDA released/g wet tissue. 
 
Reagents Sample Blank 
SDS 0.2ml 0.2ml 
Supernatant 0.2ml - 
DDW 1.6ml 1.8ml 
Acetic acid 1.5ml 1.5ml 
TBA 1.5ml 1.5ml 
n-butanol/pyridine  5ml 5ml 
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Calculation 
 
۱ܗܖ܋܍ܖܜܚ܉ܜܑܗܖ ܗ܎ 𝐌۲𝐀 =  Absorbance at ͷ͵ʹnmL × Є  × D 
Where,  
L = Light path (1cm) 
Є = Extinction co-efficient 1.56x105 M-1cm-1 
D =  Total volume ሺͳͲmlሻVolume of the sample ሺͲ.ʹmlሻ 
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12.4. Estimation of Glutathione peroxidase 81 
Reagents 
1. Phosphate buffer, pH 7.0 (75mM) 
2. Glutathione reductase (60mM) 
3. Sodium azide (0.12M) 
4. Disodium EDTA (0.15mM) 
5. NADPH (3mM) 
6. H2O2 (7.5mM) 
Procedure 
3ml cuvette containing 2.0ml of phosphate buffer (75mmol/L, pH 7.0), 50µl of 
glutathione reductase (60mmol/L), 50µl of NaN3 (0.12mol/L), 0.1ml of Na2EDTA 
(0.15mM/L), 100µl of NADPH (3.0mmol/L) and tissue supernatant were added. Water was 
added to make a total volume of 2.9ml. The reaction was started by the addition of 100µl of 
(7.5mmol/L) H2O2, and the conversion of NADPH to NADP was monitored by a continuous 
recording of the change of absorbance at 340nm at 1min interval for 5min. Enzyme activity 
of GSHPx was expressed in terms of mg of protein. 
Reagents Sample Blank 
Phosphate buffer 2.0ml 2.9ml 
Glutathione reductase 0.05ml 0.05ml 
Sodium azide 0.05ml 0.05ml 
Disodium EDTA 0.1ml 0.1ml 
NADPH 0.1ml 0.1ml 
Supernatant 0.1ml 0.1ml 
H2O2 0.1ml - 
DDW 0.5ml 0.6ml 
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Calculation 
۳ܖܢܡܕ܍ ܉܋ܜܑ𝐯ܑܜܡ ሺ𝐌 ܕܑܖ⁄ ܕܔ⁄ ሻ =  Aଷସ଴ ∕ min  × V୲ε × d ×  Vୱ  
Where,  
ε = 6.22 x 106 M-1cm-1 
d = 1cm 
Vt= Total volume (3.0ml) 
Vs= Sample volume (0.1ml) 
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12.5. Estimation of Glutathione reductase (GRD) 81 
Glutathione reductase was assayed by the method of Stahl et al. 
Reagents 
1. Phosphate buffer (0.3M; pH 6.5) 
2. EDTA (0.25M) 
3. Glutathione oxidized, GSSG (0.012M) 
4. NADPH (0.03M); Nicotinamide Adenine Dinucleotide Phosphate reduced tetra sodium salt, 
NADPH.Na4 (Mw.833.35) 
Procedure 
 The reaction mixture containing 1ml phosphate buffer, 0.5ml EDTA, 0.5ml GSSG 
and 0.2ml of NADPH was made up to 3ml with distilled water. After the addition of 0.1ml of 
tissue homogenate, the change in optical density at 340nm was monitored for 2min at 30sec 
interval. 
 One unit of the enzyme activity was expressed as nmoles of NADPH 
oxidized/min/mg protein 
Reagents Sample Blank 
Phosphate buffer 1.0ml 1.5ml 
EDTA 0.5ml 0.5ml 
GSSG 0.5ml - 
NADPH 0.2ml 0.2ml 
Supernatant 0.1ml 0.1ml 
DDW 0.8ml 0.8ml 
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Calculation 
۳ܖܢܡܕ܍ ܉܋ܜܑ𝐯ܑܜܡ ሺ𝐌 ܕܑܖ⁄ ܕܔ⁄ ሻ =  Aଷସ଴ ∕ min  × V୲ε × d ×  Vୱ  
Where,  
ε = 6.22 x 106 M-1cm-1 
d = 1cm 
Vt= Total volume (3.1ml) 
Vs= Sample volume (0.1ml) 
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 13. METHODS FOR HISTOPATHOLOGICAL STUDY 
The mice from each group were anaesthetized using intraperitoneal injection of 
thiopentone sodium. The brain was carefully removed without any injury after opening the 
skull. The collected brain was washed with ice cold normal saline and fixed in 10% formalin 
saline. Paraffin embedded sections were taken 100μm thickness and processed in alcohol-
xylene series and stained with Haematoxyli-Eosin dye. The sections were examined 
microscopically for histopathological changes in the hippocampal zone. 
 
14.  STATISTICAL ANALYSIS 
The statistical analysis was carried by one way ANOVA followed by Dunnet’s ―t‖ 
test. P values <0.05 (95% confidence limit) was considerd statistically significant, using 
Software Graph pad Prism 6.0 
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15. TABLES AND GRAPH 
Table 5: Phytochemical screening of Caryota urens 
 
 
 
 
 
 
 
 
 
S.NO CONSTITUENTS REMARKS 
1.  Alkaloids Present 
2.  Carbohydrates Present 
3.  Protein Absent 
4.  Steroids Absent 
5.  Phenols Present 
6.  Tannins Present 
7.  Flavonoids Present 
8.  Gums and Mucilage                     Absent  
9.  Glycosides Absent 
10.  Saponins Absent 
11.  Terpenes Present 
12.  Sterols Absent 
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Table 6: Effect of HAECU in acute toxicity study 
 
S.No Treatment Dose 
Weight of 
animal (g) 
Si
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D
ur
at
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n 
Before 
test 
After 
test 
1. HAECU 2000mg/kg 25 28 
N
o
 s
ig
n
s 
o
f 
to
xi
ci
ty
 
Nil Nil 14 days 2. HAECU 2000mg/kg 20 22 
3. HAECU 2000mg/kg 20 22 
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Table 7: Effect of  HAECU  in Open field  
 
 
Values are represented in Mean ± SEM, n=6 
Comparison: a- Group I vs Group II, b- Group II vs Group III and Group IV 
Statistical significance test for comparison was done by one way ANOVA followed by 
Dunnet’s‘t’ test. 
     ns- Non significant, *p<0.05, **p<0.01, *p<0.001 
 
 
 
 
 
 
 
S.no Groups 
 
No of head dipping No of line crossing 
1 Control 47.00±1.41 128.34±3.42 
2 Negative control 25.80±1.74a*** 89.60±3.07a*** 
3 Standard 39.20±1.35b*** 122.25±4.49b*** 
4 HAECU 200 mg/kg 31.80±2.39b** 102.80±2.85b** 
5 HAECU 400 mg/kg 35.60±1.32b** 110.22±1.11b*** 
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Graph 1: Effect of  HAECU  in head dipping 
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Graph 2: Effect of  HAECU  in line crossing 
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Table 8: Effect of  HAECU  in Closed field  
S.no Groups 
 
Activity scores 
1 Control 407.2±7.31 
2 Negative control 309.6±3.89a*** 
3 Standard 392.4±2.94b*** 
4 HAECU 200 mg/kg 360.4±2.94b*** 
5 HAECU 400 mg/kg 378.2±1.56b*** 
 
Values are represented in Mean ± SEM, n=6 
Comparison: a- Group I vs Group II, b- Group II vs Group III and Group IV 
Statistical significance test for comparison was done by one way ANOVA followed by 
Dunnet’s‘t’ test. 
     ns- Non significant, *p<0.05, **p<0.01, *p<0.001 
 
Graph 3: Effect of  HAECU  in Closed field 
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Table 9: Effect of  HAECU  in Passive avoidance 
S.no Groups 
 
Latency (secs) 
1 Control               43.83±1.24 
2 Negative control 26.50±0.76a*** 
3 Standard 39.50±0.53b*** 
4 HAECU 200 mg/kg 32.00±1.39b** 
5 HAECU 400 mg/kg 35.33±1.30b*** 
 
   Values are represented in Mean ± SEM, n=6 
Comparison: a- Group I vs Group II, b- Group II vs Group III and Group IV 
Statistical significance test for comparison was done by one way ANOVA followed by 
Dunnet’s‘t’ test. 
     ns- Non significant, *p<0.05, **p<0.01, *p<0.001 
Graph 4: Effect of  HAECU  in Passive avoidance 
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Table 10: Effect of  HAECU  in Y maze  
S.no 
 
Groups 
 
% Alterations 
1 Control                           48.17 
2 Negative control 30.27a*** 
3 Standard 44.40b*** 
4 HAECU 200 mg/kg 36.71b** 
5 HAECU 400 mg/kg 39.65b*** 
 
Values are represented in Mean ± SEM, n=6 
Comparison: a- Group I vs Group II, b- Group II vs Group III and Group IV 
Statistical significance test for comparison was done by one way ANOVA followed by 
Dunnet’s‘t’ test. 
     ns- Non significant, *p<0.05, **p<0.01, *p<0.001 
Graph 5: Effect of  HAECU  in Y maze 
G ro u p s
%
a
l
t
e
r
a
t
i
o
n
s
C O N N C S T D L D H D
0
2 0
4 0
6 0
C O N
N C
S T D
H A E C U  2 0 0 m g /kg
H A E C U  4 0 0 m g /kg
 
Ameriolative Effect Of Hydro Alcoholic Extract Of Caryota urens STZ Induced Alzheimer’s  
 
Department of Pharmacology Page 83 
 
Table 11: Effect of  HAECU  in MSW 
S.no Groups 
 
Escape latency(sec) 
1 Control 12.00±0.96 
2 Negative control 36.00±2.20a* 
3 Standard 12.83±1.44b*** 
4 HAECU 200 mg/kg 19.17±1.57b*** 
5 HAECU 400 mg/kg 15.33±1.25b*** 
 
Values are represented in Mean ± SEM, n=6 
Comparison: a- Group I vs Group II, b- Group II vs Group III and Group IV 
Statistical significance test for comparison was done by one way ANOVA followed by 
Dunnet’s‘t’ test. ,    ns- Non significant, *p<0.05, **p<0.01, *p<0.001 
Graph 6: Effect of HAECU in MWM 
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Table 12: Effect of  HAECU  in Dopamine 
S.no Groups 
 
ng/mg wet tissue 
1 Control 432.1±13.45 
2 Negative control 303.0±4.51a*** 
3 Standard 385.6±3.80b*** 
4 HAECU 200 mg/kg 352.9±2.44b** 
5 HAECU 400 mg/kg 367.5±4.60b*** 
 
Values are represented in Mean ± SEM, n=6 
Comparison: a- Group I vs Group II, b- Group II vs Group III and Group IV 
Statistical significance test for comparison was done by one way ANOVA followed by 
Dunnet’s‘t’ test. 
     ns- Non significant, *p<0.05, **p<0.01, *p<0.001 
 
Graph 7: Effect of  HAECU  in Dopamine 
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Table 13: Effect of  HAECU  in Serotonin 
S.no Groups 
 
ng/mg tissue 
1 Control 247.33±5.86 
2 Negative control 177.48±3.15a*** 
3 Standard 238.56±5.46b*** 
4 HAECU 200 mg/kg 203.52±2.72b** 
5 HAECU 400 mg/kg 220.00±2.92b*** 
 
Values are represented in Mean ± SEM, n=6 
Comparison: a- Group I vs Group II, b- Group II vs Group III and Group IV 
Statistical significance test for comparison was done by one way ANOVA followed by 
Dunnet’s‘t’ test. 
     ns- Non significant, *p<0.05, **p<0.01, *p<0.001 
 
Graph 8: Effect of  HAECU  in Serotonin 
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Table 14: Effect of  HAECU  in Acetylcholinesterase 
 
Values are represented in Mean ± SEM, n=6 
Comparison: a- Group I vs Group II, b- Group II vs Group III and Group IV 
Statistical significance test for comparison was done by one way ANOVA followed by 
Dunnet’s‘t’ test. 
     ns- Non significant, *p<0.05, **p<0.01, *p<0.001 
 
Graph 9: Effect of  HAECU  in Acetylcholineesterase  
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S.no Groups 
 
nmoles/mg wet tissue 
1 Control 24.53±0.67 
2 Negative control 32.40±0.9a*** 
3 Standard 18.31±0.81b*** 
4 HAECU 200 mg/kg 22.43±0.50 b*** 
5 HAECU 400 mg/kg 20.25±0.72 b*** 
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Table 15: Effect of  HAECU  in Super oxide (SOD) 
 
Values are represented in Mean ± SEM, n=6 
Comparison: a- Group I vs Group II, b- Group II vs Group III and Group IV 
Statistical significance test for comparison was done by one way ANOVA followed by 
Dunnet’s‘t’ test. 
     ns- Non significant, *p<0.05, **p<0.01, *p<0.001 
Graph 10: Effect of  HAECU  in Super oxide (SOD) 
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S.no Groups 
 
Units/mg wet tissue 
1 Control 9.48±0.40 
2 Negative control 4.51±0.25a*** 
3 Standard 9.02±0.41b*** 
4 HAECU 200 mg/kg 6.13±0.17b** 
5 HAECU 400 mg/kg 8.06±0.10b*** 
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Table 16: Effect of  HAECU  in Catalase 
S.no Groups 
 
Units/mg wet tissue 
1 Control 3.99±0.24 
2 Negative control 1.17±0.07
a*** 
 
3 Standard 2.81±0.16b*** 
4 HAECU 200 mg/kg 2.14±0.11b*** 
5 HAECU 400 mg/kg 2.49±0.18b*** 
 
Values are represented in Mean ± SEM, n=6 
Comparison: a- Group I vs Group II, b- Group II vs Group III and Group IV 
Statistical significance test for comparison was done by one way ANOVA followed by 
Dunnet’s‘t’ test. 
     ns- Non significant, *p<0.05, **p<0.01, *p<0.001 
Graph 11: Effect of  HAECU  in catalase 
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Table 17: Effect of  HAECU  in Lipid Peroxide 
S.no Groups 
 
Units/mg wet tissue 
1 Control 70.17±1.52 
2 Negative control 108.50±4.24a*** 
3 Standard 71.20±0.96b*** 
4 HAECU 200 mg/kg 86.64±1.86 b*** 
5 HAECU 400 mg/kg 75.88±1.33 b*** 
 
Values are represented in Mean ± SEM, n=6 
Comparison: a- Group I vs Group II, b- Group II vs Group III and Group IV 
Statistical significance test for comparison was done by one way ANOVA followed by 
Dunnet’s‘t’ test. 
     ns- Non significant, *p<0.05, **p<0.01, *p<0.001 
Graph 12: Effect of  HAECU  in Lipid Peroxide 
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Table 18: Effect of HAECU  in Gpx 
 
Values are represented in Mean ± SEM, n=6 
Comparison: a- Group I vs Group II, b- Group II vs Group III and Group IV 
Statistical significance test for comparison was done by one way ANOVA followed by 
Dunnet’s‘t’ test. 
     ns- Non significant, *p<0.05, **p<0.01, *p<0.001 
Graph 13: Effect of HAECU  in Gpx 
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S.no Groups 
 
Units/mg wet tissue 
1 Control 7.61±0.26 
2 Negative control 3.90±0.18a*** 
3 Standard 7.02±0.27b*** 
4 HAECU 200 mg/kg 5.18.±0.27 b*** 
5 HAECU 400 mg/kg 5.86±0.16 b*** 
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Table 19: Effect of HAECU  in Grd 
S.no Groups 
 
Units/mg wet tissue 
1 Control 3.96±0.28 
2 Negative control 1.88±0.20a*** 
3 Standard 3.85±0.19b*** 
4 HAECU 200 mg/kg 2.85±0.22 b** 
5 HAECU 400 mg/kg 3.57±0.23 b*** 
 
Values are represented in Mean ± SEM, n=6 
Comparison: a- Group I vs Group II, b- Group II vs Group III and Group IV 
Statistical significance test for comparison was done by one way ANOVA followed by 
Dunnet’s‘t’ test. 
     ns- Non significant, *p<0.05, **p<0.01, *p<0.001 
Graph 14: Effect of HAECU  in Grd 
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16. RESULTS  .   
16.1 PRELIMINARY PHYTOCHEMICAL ANALYSIS  
 The preliminary phytochemical analysis on HAECU revealed the presence of various 
phytoconstituents including alkaloids, carbohydrates, tannins, flavonoids, gums, mucilage, 
etc. which are given in Table 5.  
16.2.ACUTE ORAL TOXICITY STUDIES  
 The acute oral toxicity was done according to OECD 423(acute toxic class method) 
guidelines. A single administration of starting dose of 2000mg/kg of body weight p.o. of 
HAECU was administered to the three female mice and observed for three days. There was 
no change in the body weight before and after treatment of the experiment and no sign of 
toxicity were observed. Observations are shown in table 6 
16.3. HABITUATION STUDIES  
16.3.1. Effect of HAECU on open field activity  
  The Group II animals showed significant decrease in head dipping and line crossing 
when compared with Group I animals (p<0.001). Treatment with HAECU (200 and 
400mg/kg) showed increased  head dipping and line crossing behaviour statistically (p<0.01 
and p<0.001 for Groups IV and V respectively) and Group III also showed increased head 
dippings and line crossings behaviour significantly (p<0.001) when compared with Group II. 
Results are given in Table 7 and plotted in Graph 1 and 2. 
16.3.2. Effect of HAECU on closed field activity  
  There was a significant (p<0.001) decrease in the activity scores produced by Group 
II animals when compared with Group I animals. Treatment with HAECU (200 and 
400mg/kg) and the standard drug showed significant (p<0.001, p<0.001 and p<0.001 for 
Group III, IV and V respectively) increase in the activity scores when compared with Group 
II animals. Results are given Table 8 and plotted in Graph 3.  
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16.4. ASSESMENT OF LEARNING AND MEMORY  
16.4.1. Effect of HAECU on Step down Passive Shock Avoidance test  
 The Step Down Latency (SDL) of Group II animals were significantly decreased 
(p<0.001) when compared with Group I animals. Treatment with HAECU (200 and 
400mg/kg) and standard drug (p<0.001, p<0.01 and p<0.001 for Group III, IV and V 
respectively) showed significant increase in step down latency when compared with Group II. 
The increase in SDL indicates increase in short term memory. Results are given Table 9 and 
plotted in Graph 4.  
16.4.2. Effect of HAECU on Y maze task  
  The percentage of alteration was significantly decreased in Group II when compared 
with Group I animals significantly (p<0.001). Treatment with HAECU (200 and 400mg/kg) 
showed significantly increased in the percentage of alteration, (p<0.01 and p<0.001 for 
Group IV and V respectively) when compared to Group II animals. Standard drug also 
(p<0.001) showed significantly increased in the percentage of alteration when compared 
Group II animals. Results are given Table 10 and plotted in Graph 5.  
16.4.3. Effect of HAECU on Morris water maze task  
  The escape latency of Group II animals were significantly increased when compared 
with Group I animals (p<0.05). ). Treatment with HAECU (200 and 400mg/kg) and standard 
drug showed significant decrease (p<0.001, p<0.001 and p<0.001 respectively) in the escape 
latency onto the hidden platform when compared with Group II animals. The decrease in 
escape latency indicates memory retention and non spatial working memory. Results are 
given Table 11 and plotted in Graph 6.  
16.5.INVITRO BIOCHEMICAL ESTIMATIONS (NEUROTRANSMITTER LEVELS)  
16.5.1. Effect of HAECU on Dopamine  
  The brain dopamine level in Group II animals were significantly decreased (p<0.001) 
when compared with Group I animals. Treatment with HAECU (200 and 400mg/kg) and 
standard drug showed (p<0.01, p<0.001 and p<0.001 respectively) significant increase in 
dopamine level on comparison with Group II animals. Results are given Table 12 and plotted 
in Graph 7.  
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16.5.2. Effect of HAECU on serotonin  
  The serotonin level in the brain of Group II animals were decreased significantly 
(p<0.001) when compared with Group I animals. Treatment with HAECU (200 and 
400mg/kg) significantly increased the serotonin level (p<0.01 and p<0.001) when compared 
with Group II animals. Standard drug also (p<0.001) showed significantly increased level of 
serotonin when compared Group II animals. Results are given Table 13 and plotted in Graph 
8.  
16.5.3. Effect of HAECU on Acetylcholinesterase  
  The level of AChE in Group II animals showed (p<0.001) significant increase when 
compared with Group I animals. Treatment with HAECU showed significant decrease 
(p<0.01 and p<0.001 for Group IV and V animals respectively) in the AChE level when 
compared with Group II animals. Group III (p<0.001) showed significant reduction in AChE 
activity when compared with Group II animals. Results are given Table 14 and plotted in 
Graph 9.  
16.6 EFFECT ON ANTIOXIDANT ENZYMES  
16.6.1.Effect of HAECU on Superoxide Dismutase  
 The SOD in the brain of Group II animals were decreased significantly (p<0.001) 
when compared with Group I animals. Treatment with HAECU (Group IV and V) and Group 
III showed (p<0.01, p<0.001 and p<0.001) significant increase in SOD on comparison with 
Group II animals. Results are given Table 15 and plotted in Graph 10.  
16.6.2. Effect of HAECU on Catalase  
  The Catalase in the brain of Group II animals were decreased significantly (p<0.001) 
when compared with Group I animals. Treatment with HAECU (Group IV and V) and Group 
III showed (p<0.001, p<0.001 and p<0.001) significant increase in Catalase on comparison 
with Group II animals. Results are given Table 16 and plotted in Graph 11.  
16.6.3. Effect of HAECU on Lipid peroxidase  
  The Lipid peroxidase in the brain of Group II animals were decreased significantly 
(p<0.001) when compared with Group I animals. Treatment with HAECU (Group IV and V) 
and Group III showed (p<0.001, p<0.001 and p<0.001) significant decrease in Lipid 
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peroxidase on comparison with Group II animals. Results are given Table 17 and plotted in 
Graph 12.  
16.6.4. Effect of HAECU on Glutathione peroxidase  
  The Glutathione peroxidase in the brain of Group II animals were decreased 
significantly (p<0.001) when compared with Group I animals. Treatment with HAECU 
(Group IV and V) and Group III showed (p<0.001, p<0.001 and p<0.001) significant increase 
in Glutathione peroxidase comparison with Group II animals. Results are given Table 18 and 
plotted in Graph 13.  
16.6.5. Effect of HAECU on Glutathione reductase  
 The Glutathione reductase in the brain of Group II animals were decreased 
significantly (p<0.001) when compared with Group I animals. Treatment with HAECU 
(Group IV and V) and Group III showed (p<0.01, p<0.001 and p<0.001) significant increase 
in Glutathione reductase comparison with Group II animals. Results are given Table 19 and 
plotted in Graph 14.  
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16.7 ASSESMENT OF HISTOPATHOLOGICAL CHANGES  
  It was observed that there was decrease in density of neuronal cells and disrupted in 
the normal distribution of neuronal cells in hippocampal region in Group II animals with 
respect to Group I animals. Treatment groups (Group III, IV and V) exhibited improved 
neuronal configuration than Group II. Group IV, V showed significant improvement in the 
density of neuronal cells and hippocampal regions of brain when compared with neuronal 
loss in negative control group (Group II). Whereas Group III showed improved  in the density 
of neuronal cells and hippocampal regions. Amount of amyloid plaques and tau tangles in 
Group III, IV, V are less when compared to Group II. Histopathological pictures are shown in 
FIG 8 to 12   
 
 
 
 
 
Fig 8: Control 
       
     Cortex        Hippocamus 
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   Fig 9: Negative control 
      
 Cortex       Hippocampus       
 
Fig 10: Standard  
        
 Cortex       Hippocamus 
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Fig 11: Low dose 
         
Cortex       Hippocamus 
 
Fig 12: High dose  
           
 Cortex       Hippocamus 
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17. DISCUSSION  
Alzheimer’s disease (AD) is now the most common cause of dementia . The incidence 
of AD increases with age . Impairment of short-term memory usually is the first clinical 
feature. When the condition progresses, additional cognitive abilities are impaired, as the 
ability to calculate, and use common objects and tools. Acetylcholine esterase inhibitors are 
the only agents approved by the Food and Drug Administration (FDA) for the treatment of 
AD. All other agents prescribed for the treatment of AD are used on an off- label basis. 
As per previous studies caryota urens has excellent antioxidant property, hence it is 
believed to have actions on CNS disorders and neurodegeneration diseases. 
The present study has revealed the ameliorative effect of HAECU on STZ induced 
Alzheimer’s disease in mice. STZ induced impairment of memory was assessed by using 
various behavioral parameters like Passive avoidance task, Y maze task, and Morris water 
maze test. It was found that treatment with HAECU protect cognitive deficits in STZ induced 
Alzheimer’s disease.  
 Spatial learning in the open field habituation was approached to access learning and 
memory. The decrease in response to a normal environment after repeated exposures to the 
familiar environment is referred to spatial habitual learning. Recurrent exposure produces a 
decrease in the exploratory initiatives, which is implicative of memory pertaining to a 
specific feature of that environment. Exploratory activities may be reduced on subsequent 
contact with open field. In the result of this study reduced by the group of animals treated 
with HAECU indicated increased spatial habitual learning and sleep deprivation decreased 
spatial habitual learning.    
Passive avoidance behavior based on negative reinforcement was used to examine the 
level of memory. An electric shock is as reinforcement during training sessions for 15 sec in 
the Step Down Latency (SDL) was recorded. SDL was defined as the time taken by the 
mouse to step down from the wooden platform to grid floor with its entire paw on the grid 
floor. SDL is increased as form of long term memory where STZ induced animals showed 
decreased SDL. Treatment with HAECU at test dosages showed improvement in long term 
memory as index of increase in SDL.   
Y maze task is one of the simplest versions of spontaneous alteration task which is 
used to measure spatial working memory. The ability to alternate requires that the mice know 
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which arm they have already visited. Normal mice are expected to exhibit an alteration 
percentage of 60-70. Pretreatment with amnesic agents prior to trials may reduce spontaneous 
alteration percentage and agents possessing memory enhancing effects are expected to 
reverse these changes. According the animals which were STZ induced had a reduced 
spontaneous alteration but animals treated with HAECU produced a significant increase in 
alteration which was comparable to the untreated control which in turn indicates the 
increased spatial working memory of the animals.  
Morris water maze task represents more specific for spatial memory. The essential 
feature f this technique is that mice are placed into large circular pool f water and can escape 
into a hidden platform. Thus, the platform offers no local  cues to guide escape behavior and 
the mouse can escape from swimming by climbing on to the platform apparently learns the 
spatial location of the platform any starting position at the circumference of the pool. The 
only spatial cues are those outside water tank are primarily visual cues. Thus, the versatility 
of the task makes it a widely acceptable experimental model for the assessment of cognitive 
tests. Typically, STZ induced animals exhibited an increase time for escape latency indicating 
loss of visual cues to escape n to the platform. Such a diminished cognition was reversed by 
the administration of the HAECU at the specified dosage levels and exhibited escape latency 
(EL), indicating the well- developed spatial memory inspite of STZ induced Alzheimer’s 
disease.  
Both nicotinic and muscarinic cholinergic receptors are involved in cognitive and 
memory functions and several studies have suggested their roles in dementia. Marked 
cholinergic deficit is a hallmark of the pathogenesis of AD and various drugs including AchE 
inhibitors have designed to target this deficit, initially, cholinergic deficit was thought to be a 
muscarinic nature, but recent study show a specific loss of nicotinic acetyl choline receptors 
and marked loss of cholinergic neurons. There was a significant reduction in the level of 
acetylcholine esterase in the animals treated with HAECU and increased Ach regulate the 
impaired memory by STZ induction.    
Serotonin is the critical neurotransmitter modulating short term habituation in 
Aplysia. In general, hippocampal depletions deleteriously affect habituation in the open field, 
but rodents also commonly exhibit decreased locomotor and exploratory activity.   
The formation of new memories is thought to require the hippocampus and adjacent 
medial temporal lobe, but the final storage of memories is widely distributed by neocortical 
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network. Lesion studies have suggested that there is a wide distribution of neocortical 
memory traces encoded in the strength of synaptic connections among neurons across large 
areas of the neocortex. Although, glutamate and GABA receptors play a major role in 
learning and memory, serotogenic effects have also been detected and on the region 
implicated in memory storage are richly innervated by the serotogenic system.  
It has been suggested that antioxidant might contribute to the prevention of AD. The 
superoxide dismutase (SOD) constitutes a mutually supportive team of defense against 
reactive oxygen species. The most remarkable effect of HAECU is increased activity of SOD 
in hippocampus. Treatment with HAECU preserved the reduced SOD to that of the normal 
control.    
Usually increased level lipid peroxide causes oxidative stress. The HAEECU has 
better action on lipid peroxide , since the levels of lipid peroxide is reduced in the treatment 
groups. 
Glutathione (GSH) is the major non-protein thiol antioxidant in mammalian cells and 
is considerd the main intracellular redox buffer. GSH protects cellular protein thiols against 
irreversible loss, thus preserving protein function The administration of HAECU significantly 
preserved the activity of GSH, GPx in the hippocampus to similar level observed in normal 
control mice. The restoration of activities of GSH, GPx by HAECU might promote 
scavenging of free radicals using recycled GSH from GSSG.  
.  
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18. CONCLUSION 
 The selected dose 200mg/kg and 400mg/kg  of caryota  urens showed significant 
action in memory and  learning processes  but higher dose 400mg/kg showed better action 
than lower dose 200mg/kg. 
The present study relieved the action of caryota urens on streptozotocin induced 
alzheimer’s disease on mice model. From the results it can be concluded that caryota urens 
remarkable effect in memory enhancement and oxidative stress. Further studies are required 
for the identification of molecular level action and individual phytoconstitutent that may 
responsible for CNS action. 
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